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”It is pretty remarkable to think that our brains, which are essentially a collection of
particles working to the laws of physics, have this wonderful ability to not only perceive
reality, but to give it meaning to. The meaning of life is what you choose it to be.
Personally I like to think that it is everyone of us who gives meaning to the Universe.
We are as cosmologist Carl Sagan said ’the Universe contemplating itself ’.
Meaning can only ever exist within the confines of the human mind and in this way the
meaning is not somewhere out there, but right between our ears. In many ways this
makes us the lords of the creation.”
Stephen Hawkings
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Kurzfassung
Die Herstellung, Charakterisierung und biologische Auswertung von verschiedenen
Graphen-basierten Nanopartikeln mit einer potenziellen biomedizinischen Anwendung
wurden erforscht. Die vorgestellten Ergebnisse im Rahmen dieser Arbeit zeigen, dass
eukaryotische Zellen unterschiedlich reagieren können, wenn sie mit Nanopartikeln un-
terschiedlicher Morphologie interagieren. Die Zellen können geringe Unterschiede in der
Morphologie, insbesondere der Größe der Nanopartikeln, identifizieren. Dies unterstre-
icht den Einfluss der Herstellungsmethoden und die Notwendigkeit einer gründlichen
Charakterisierung, um ein effektives Design von Nanopartikeln für biologische Anwen-
dungen zu erreichen.
Um den Einfluss der Größe von Graphen-basierten Nanopartikel auf das Zellverhalten
zu erforschen, wurden verschiedene Graphen-beschichte Eisenoxid-Nanopartikelproben
durch eine kolloidchemische Methode hergestellt. Dieses Herstellungsverfahren ermöglicht
die Synthese von Nanopartikeln mit engen Größenverteilungen, die als monodispers gel-
ten können. Vier Proben mit unterschiedlichen Durchmessern (von 10 bis 20 nm) wur-
den hergestellt und vor den biologischen Untersuchungen systematisch charakterisiert.
Die Probencharakterisierung deutet auf eine Mischung aus Magnetit- und Maghemit-
Kristallphasen hin, außerdem besitzen die Nanopartikel eine dünne Graphitschicht. Die
spektroskopischen Ergebnisse auch zeigen außerdem, dass alle Proben funktionelle Grup-
pen auf ihrer Oberfläche besitzen, sodass sie in allen Aspekten, außer Morphologie
(Durchmesser), ähnlich sind. Die biologischen Untersuchungen deuten darauf hin, dass
Zellen unterschiedliche Größen von Eisenoxid-Nanopartikeln reagieren können.
Ein in situ Untersuchung der Beschichtung der Eisenoxid-Nanopartikel wurde mit einem
Transmissionelektronenmikroskop durchgeführt. Die Ergebnisse zeigen, dass eine dünne
Schicht von Ölsäure aus dem Syntheseprozess auf den Nanopartikeln verbleibt. Diese
Schicht kann mit einem Elektronstrahl in Graphen umgewandelt werden. Die Dicke der
Graphitschicht auf den Nanopartikeln kann durch die Menge der eingesetzten Ölsäure
kontrolliert werden. Die in situ Beobachtungen der Graphenumwandlung konnte durch
erhitzen der Nanopartikeln in einem dynamischen Vakuum reproduziert werden. Das
Brennen der Eisenoxid-Nanopartikel ermöglicht nicht nur die Graphitisierung der Ölsäure,
sondern auch eine Verbesserung der magnetischen Eigenschaften der Nanopartikel für
weitere Anwendungen, z. B. der Hyperthermie. Die Umwandlung der Ölsäure in
Graphen konnte so als relativ einfaches Verfahren der Beschichtung von zweidimen-
sionalen (2D) Substraten etabliert werden.
Die Herstellung von Nanographenoxid mit unterschiedlichen Größen wurde mit der
Hummers-Method durchgeführt. Die unterschiedlichen Größen der Nanographenoxid-
partikel wurde durch eine Behandlung in Ultraschallbad erreicht. Zwei Proben mit deut-
licher Verteilung wurden mit mehreren Verfahren charakterisiert. Beide Proben haben
Nanographenoxid Nanoteilchen mit verschiedenen funktionellen Gruppen. Die biologis-
che Charakterisierung deutet darauf hin, dass unterschiedliche Größen des Nanographens
ein unterschiedliches Zellverhalten auslösen.
Abschließend, wurde die Herstellung, Charakterisierung und biologische Auswertung von
Graphen-Nanoschalen durchgeführt. Die Graphen-Nanoschalen wurden mit
Magnesiumoxid-Nanopartikeln als Template hergestellt. Die Beschichtung des Magne-
sia mit Graphen erforgte durch die chemische Gasphasenabscheidung. Die Nanoschalen
wurden durch Entfernen des Magnesia-Kerns erhalten. Die Größe der Nanohüllen ist
durch die Größe der Magnesia-Kerns bestimmt und zeigt eine breite Verteilung, da der
Durchmesser der Magnesiumoxid-Nanopartikel gegeben war. Die Nanoschalen wurden
ebenfalls mit Infrarot- und Röntgen Photoemissionspektroskopie charakterisiert und die
biologische Bewertung wurde im Eidgenössische Materialprüfungs- und Forschungsanstalt
(EMPA) durchgeführt, in der Schweiz. Die Ergebnisse zeigen, dass zwar die Produktion
von reaktiven Sauerstoffspezies in den Zellen ausgelöst wird, diese sich aber weiterhin
vermehren können.
Abstract
The synthesis, characterization and biological evaluation of different graphene-based
nanoparticles with potential biomedical applications are explored. The results presented
within this work show that eukaryotic cells can respond differently not only to different
types of nanoparticles, but also identify slight differences in the morphology of nanopar-
ticles, such as size. This highlights the great importance of the synthesis and thorough
characterization of nanoparticles in the design of effective nanoparticle platforms for
biological applications.
In order to test the influence of morphology of graphene-based nanoparticles on the
cell response, nanoparticles with different sizes were synthesized and tested on different
cells. The synthesis of spherical iron-oxide nanoparticles coated with graphene was ac-
complished using a colloidal chemistry route. This synthesis route was able to render
nanoparticle samples with narrow size distributions, which can be taken as monodis-
persed. Four different samples varying in diameter from 10 to 20 nm were produced and
the material was systematically characterized prior to the biological tests. The charac-
terization of the material suggests that the iron oxide nanoparticles consist of a mix of
both magnetite and maghemite phases and are coated with a thin graphitic layer. All
samples presented functional groups and were similar in all aspects except in diameter.
The results suggest that cells can respond differently even to small differences in the size
of the nanoparticles.
An in situ study of the coating of the iron-oxide nanoparticles using a transmission elec-
tron microscope revealed that it is possible to further graphitize the remaining oleic acid
on the nanoparticles. The thickness of the graphitic coating was controlled by varying
the amount of oleic acid on the nanoparticles. The in situ observations using an electron
beam were reproduced by annealing the nanoparticles in a dynamic vacuum. This proce-
dure showed that it is not only possible to coat large amounts of iron oxide nanoparticles
with graphene using oleic acid, but also to improved their magnetic properties for other
applications such as hyperthermia. This study therefore revealed a facile route to grow
2D graphene flakes on substrates using oleic acid as a precursor.
The synthesis of nanographene oxide nanoparticles of different sizes was in a second ap-
proach accomplished by using the Hummers method to oxidize and expand commercially
available graphite. The size of the oxidized graphite was adjusted by sonicating the sam-
ples for different periods of time. The material was also thoroughly characterized and
demonstrated to have two distinctive average size distributions and possess functional
groups. The results suggest that different size flakes can trigger different cell response.
The synthesis, characterization and biological evaluation of graphene nanoshells were
performed. The graphene nanoshells were produced by using magnesia nanoparticles as
a template to the graphene nanoshells. The coating of magnesia with graphene layers
was accomplished using chemical vapor deposition. The nanoshells were obtained by
removing the magnesia core. The size of the nanoshells was determined by the size of
the magnesia nanoparticles and presented a broad size distribution since the diameter
of the magnesia nanoparticles could not be controlled. The nanoshells were also char-
acterized and the biological evaluation was performed in the Swiss Federal Laboratories
for Materials Science and Technology (EMPA), in Switzerland. The results suggest that
despite inducing the production of reactive oxygen species on cells, the nanoshells did
not impede cell proliferation.
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Chapter 1
Motivation
The main focus areas of nanotechnology have been to understand the correlation between
optical, thermal, electrical and magnetic properties of nano-structured materials with
respect to their morphological aspects such as their size, shape and surface chemistry
[1, 2]. Such studies are providing knowledge for engineering nanotechnology-based elec-
tronic, computer and biomedical devices. A recent trend in nanotechnology has been to
investigate the interactions between nano-structured materials with biological systems
[3].
Currently we are unable to draw a specific nor a general conclusion regarding the impact
of size, shape and surface chemistry-dependant interactions of nano-structured materials
with biological systems. The morphological features of nanoparticles alone are thought
to trigger different biological responses without any dependence of the material they
are made of or type of surface functionalization that they have. Hence, it is of cru-
cial importance that novel approaches be developed, which can be used to synthesize
nanoparticles with a very homogeneous nature. This provides not only the means to
obtain accurate and valuable knowledge about the controlled synthesis of nanoparticles,
but also, the crucial possibility to precisely study what is the role that the intrinsic
properties of nano-structured materials play when interacting with biological cells.
Typically, nanoparticles with a single or combination of known variable(s) (e.g. size,
or shape and surface chemistry) are exposed to a biological system and a biological re-
sponse is measured [3]. However, most of nanoparticles samples synthesized and tested
for biological applications pursue a very inhomogeneous nature and have nanoparticles
in a wide range of sizes (broad distributions), different shapes and consequently different
surface chemistry and defects (Figure 1.1).
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Figure 1.1: Samples containing nanoparticles normally contain particles with different
sizes, shapes and defects. These mixed and inhomogeneous samples are not sufficiently
adequate to get an accurate conclusion of how biological systems are responding, since
many of the morphological aspects may trigger specific influences in biological cells.
One way to overcome this problem is to synthesize nanoparticles with well-defined mor-
phological features (Figure 1.2) and systematically examine one nanostructure parameter
at a time.
Figure 1.2: Samples containing nanoparticles with same sizes, shapes and defects.
These homogeneous samples are adequate to get an accurate conclusion of how biolog-
ical systems are responding to one single specific morphological aspect under study.
Only then it is possible to individually study what the role that the nanoparticles are
playing is when in contact with biological systems, as well as draw accurate correlations
between the nanoparticle design and a specific biological response (Figure 1.3). These
data can then finally be used to build a database to develop predictive software on how
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specific features of nanoparticles is linked to specific biological responses [3, 4].
Figure 1.3: Illustration showing the most important nanoparticle parameter, biologi-
cal systems, biological responses studied and potential application. The morphological
aspects of nanoparticles must be controlled since the synthesis and individually studied
in biological systems. In this way, it is possible to create accurate correlations between
morphology and biological response. Image with permission ([3])
The inspiration to create such database is linked to natural design. Molecules, viruses,
bacteria and other biological structures have evolved into precise sizes, shapes, and
chemistries to mediate specific interactions and functions. For example, viruses are
icosahedral, bullet-shaped, rod-shaped or can have asymmetric morphologies. These
geometries are thought to play an important role in their ability to infect specific cell
types and may alter their residence time inside the cell. Another example is the assemble
of proteins in complex units, such as ribosomes, in order to regulate cell viability and
function [3]. To date the physicochemical properties of naturally occurring nano-sized
complexes and structures are far from being fully understood. However, it is clear that
these biological structures follow specific design rules [5]. Hence, in order to engineer
nanostructures capable of specific functions such as circulate in the body, infect and
control cells, detect and repair unhealthy cells, it is crucial to understand how synthetic
nano-structured materials interact with biological systems.
Initial studies on nano-structured materials did not consider the final application to
guide the design of nanoparticles. Instead, the focus was predominantly on engineering
materials with specific physical or chemical properties. For example, when designing
nanoparticles for cancer diagnosis, the focus is mainly to improve detection sensitivity by
taking into account only optical and magnetic properties of nanoparticles. However, the
efficiency by which cells internalize these materials plays a dominant role in determining
the signal intensity. Hence, by understanding how geometrical aspects of nanoparticles
influence their delivery into cells, one is able to redesign the nanoparticle so that they
accumulate maximally inside in the tumor [3].
The aim of this work is to synthesize carbon-based nanoparticles, namely iron oxide
Chapter 1. Motivation 4
coated with graphene and nano graphene oxide, with defined morphological aspects and
investigate their morphological role on toxicity and uptake when interacting with both
cancer and non cancer cells.
Chapter 2
Introduction
This introductory chapter is dedicated to present a brief overview on sp2 carbon hy-
bridization as well as the main carbon allotropes known to date resulting from the hy-
bridization capability of elemental carbon . The chapter also reviews the synthesis routes
used to synthesize carbon nanostructures and covers the main biological functionaliza-
tion of carbon nanostructures as well as the main biomedical applications where these
nanostructures can be applied.
2.1 sp2 hybridization
Hybridization refers to the concept of mixing atomic orbitals into new hybrid orbital,
which are suitable for the pairing of electrons to form chemical bonds. The element
carbon (C) is one of the most versatile elements in terms of the compounds it may form.
In fact, carbon can form single, double and triple bonds and can have different types of
spn hybridization where n ranges from one to three. The carbon atom has 6 electrons.
Two of these electrons are located in the 1s shell, two are located in the 2s shell and
the remaining two are located in the 2p shell. The four electrons localized in the outer
orbitals (2s and 2p) can mix easily and are responsible for the formation of different spn
hybridization. In this work the focus is on the sp2 hybridization. The sp2 hybridization
is one of the most attractive and studied of the hybridizations, where both the 2s and
2p electrons mix with each other. Usually, three of those electrons (σ electrons) form
a strong trigonal binding with the neighboring atoms. The forth electron (π electron)
forms a weak and perpendicular bond to the trigonal plane. Figure 2.1 illustrates the
formation of sp2 hybridization.
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Figure 2.1: In A it is shown the orbitals responsible for the formation of sp2 hy-
bridization. In B it is shown the geometry of the sp2 hybridization and in C it is shown
the formation of π- and σ-bonds [6].
2.2 sp2 carbon allotropes
The different possible hybridizations in carbon allow this element to exist in a large va-
riety of natural and synthetic allotropes. The elemental carbon exists in two natural al-
lotropes, diamond and graphite, which consists of sp3- and sp2-hybridized carbon atoms,
respectively. Both forms present unique physical properties such as hardness, thermal
conductivity, lubrication behavior or electrical conductivity [7]. There are many other
synthetic allotropes described in literature with sp2 hybridization. The most studied
synthetic allotropes of carbon are the fullerenes, single-walled carbon nanotubes and
graphene. However, other structures such as nanodiamond, and carbon nanohorns can
also be taken as synthetic carbon allotropes. These structures will be briefly described
in section 2.3 of this chapter. Recently, the combination of sp- sp2 and sp3-hybridized
carbon leads to many possible two- and three-dimensional carbon allotropes, such as
graphyne [8]. The wide variety of artificial carbon allotropes is so attractive not only
because of their different structure, but also because of their outstanding properties [7].
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It is common to fullerenes, carbon nanotubes and graphene the presence of fully conju-
gated π-electrons. This conjugation leads to pronounced redox activity and outstanding
electronic properties. However, the vast potential of carbon nanostructures comes from
the ability of chemical functionalization, which enables them to dramatically increase
their solubility in any solvent and transform these molecules into more biocompatible
platforms for further biological applications. The chemical functionalization provides
the unique possibility to unite the intrinsic properties of the nanostructure with those
of other compounds. The possible chemical functionalizations of carbon nanostructures
will be covered in the next two sections of this chapter.
2.3 Carbon-based nanoparticles
As mentioned in section 2.2. The variety of natural and artificial carbon allotropes is
astounding and many of these carbon structural formations have exciting electronic, me-
chanical and physicochemical properties at the nanoscale. Indeed, their promising nano-
based properties have excited scientists and engineers for a number of years, particularly
in materials science and molecular electronics. More recently, we are just beginning to
realise how these wonderful structures can be exploited for their drug delivery and di-
agnostic potential. To this end, thus far, the following carbon-based nanostructures
are being explored: graphene, fullerenes, carbon nanohorns, nanodiamonds and metallic
nanoparticles coated with graphene. It is important to mention here that despite all the
main carbon allotropes are described in this chapter, the experimental focus of this work
concentrates on the metallic nanoparticles coated with graphene and oxidized graphene
nanoflakes.
2.3.1 0-Dimensional carbon nanoparticles
Zero-dimensional (0D) carbon nanoparticles encamps the fullerenes, which were discov-
ered in 1985 by Robert Curl, Harold Kroto and Richard Smalley at Rice University and
Sussex University. Fullerenes are named after Richard Buckminster Fuller, a famous
architect known for his geodesic domes. Fullerenes can exist with different numbers of
carbon atoms in their structure giving them different shapes and sizes. The most famous
fullerene form is the C60 molecule (buckyball) which contains 60 carbon atoms. Carbon
atoms in this object are linked together forming 20 hexagonal and 12 pentagonal rings,
similar to a traditional football. The C60 structure can be seen in Figure 2.2.
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Figure 2.2: Chemical structure representing the C60 molecule.
Other fullerene forms are C70, C72, C76, C84 and C100. Gram quantities of fullerenes were
synthesized in 1990 for the first time by two physicists W. Krätschmer and D.R. Huffman
by creating an arc between two graphite electrodes in a quenching atmosphere of helium
[9]. Other methods to produce fullerenes are: the vaporization of graphite by heating in
an inert gas [10], combustion of unsaturated hydrocarbons in flames [11], focusing sun-
light on a graphite carbon target [12], laser ablation of graphite (the technique in which
fullerenes were first discovered) [13] and the laser ablation of polymers [14]. A substan-
tial fraction of the as-produced black soot like material consists of fullerenes. Mixed
within the product are graphitic and amorphous impurities. Therefore the fullerenes
need to initially be separated from unwanted species by sublimation via heating in an
inert gas or in vacuum or by salvation, usually, using toluene due to good solubility in
this medium (2.8 mg/ml) [15]. The resultant fullerene material contains C60 ∼ 80%,
C70 ∼ 20% and 1% of larger fullerenes. The various fullerene types are then frac-
tioned using flash-chromatography. At this final stage the toluene is removed using a
rotary evaporator [16, 17]. Due to the unique carbon cage structure of fullerenes they
can be easily functionalized with a wide range of molecules (endohedral and exohedral
functionalization) [18–25]. This makes them promising for biomedical applications in
therapeutics and diagnostics. However, fullerenes are hydrophobic, which restricts their
direct use in bio-applications [26]. Hence, in order to make them viable as candidates
for bio-applications they need to be suitably prepared. This is usually accomplished
via surface functionalization. This includes chemical functionalization with e.g. amino
acid, carboxylic acid, polyhydroxyl groups, amphiphilic polymers [27–30], therapeutic
agents e.g. chemotherapeutics [31], or encapsulation of fullerenes in special carriers such
as cyclodextrins [32] or calixarenes [33], polivinylpyrrolidone [34], micelles and lypo-
somes [35]. Chemotherapeutic agents for cancer therapies can ”decorate” the surface of
fullerenes together with specific antibodies for targeted delivery; viz. the antibody guides
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the fullerene directly to the cancer cell by tracking its chemical signature [36]. Due to
the unique structure of fullerenes which contain 30 conjugated double bonds, fullerenes
can easily interact with other molecules and also react with free radicals and not be
consumed in the process. An interesting derivative for free radical scavenging purposes
is fullerenol (C60(OH)24). Fullerenol is usually prepared by adding NaOH solution and
TBAH (tetrabutylamonium hydroxide) to a C60 toluene solution and thereafter, the
functionalized fullerenes are separated from the organic and water phases [23]. Their
free radical scavenging potential has been demonstrated both in vitro [37] and in vivo
[38]. Another free radical scavenger is carboxyfullerene (C60C(COOH)2)2. The prepa-
ration of this structure is usually performed by mixing C60 with diethyl bromomalonate
under base conditions [23]. Carboxyfullerenes can protect quiescence in human periph-
eral blood mononuclear cells against programmed cell death (apoptosis) [39] or can be
used for the treatment of Parkinson’s disease [40]. Another class of fullerene deriva-
tives are the endohedral metallofullerenes, which are fullerenes with metal ions trapped
inside their cage (Figure 2.3). The metal atoms in these structures take off-center po-
sitions in the fullerene cages and electrons transfer from the metal atom to the cage.
The preparation of doped metal fullerenes is achieved via laser evaporation or in an arc
reactor. They hold potential for medical diagnostics inside living organisms as contrast
agents for magnetic resonance imaging (MRI). The most common endohedral fullerenes
used for biomedical applications are: Gadolinium (Gd3+) [24, 25, 41], Scandium (Sc)
[108], Holmium (Ho3+) [42], Thulium (Tm2+) [43], Gallium (Ga3+) [44] and Technetium
(Tc2+) [45]. The basic concept of these fullerene derivatives as MRI agents, is to isolate
unstable metal atoms inside their carbon cages in order to protect against interaction
with the outside environment, viz. to prevent any toxic influence. Before inserting en-
dohedral fullerenes to living organisms they must be functionalized exohedrally in order
to allow them to cross cell membranes.
Figure 2.3: Example of an endohedral fullerene.
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Tests have shown that fullerenes and their derivatives have no observable influence on
in vitro cytotoxicity [18, 46]. The distribution and metabolism of fullerene derivatives
in living organisms is today extensively investigated. They can accumulate in specific
places in the bodies, e.g. liver or bones (Ho3+ metallo-fullerenes) enabling detailed MRI
imaging of specific areas. Various studies have shown that metallo-fullerenes applied to
living organisms display ultra low levels of radioactivity. Moreover, endohedral fullerenes
stay in the body after the application for approximately one hour, which is sufficient to
image the circulatory system.
2.3.2 1-Dimensional carbon nanoparticles
The 1-dimensional carbon nanostructures are formed by the carbon nanotubes (CNTs).
The current excitement in CNTs was triggered by Sumio Iijima’s Nature publication
in 1991[47]]. Their diameters range from sub nanometers to several hundred nm’s.
Their lengths can reach a few centimetres[48]. CNTs are artificial allotropes of carbon
consisting of a single or multiple graphene layers rolled up concentrically and hence have
a cylindrical structure (Figure 2.4).
Figure 2.4: Chemical sketch representing a carbon nanotube.
When the tubes are formed from a single graphene sheet then the structures are called
single-walled carbon nanotubes (SWCNTs). In the case of multiple concentric sheets
the structures are called multi-walled carbon nanotubes (MWCNTs). There are many
routes to produce SWCNTs and MWCNTs. The most well-known are the flame synthe-
sis, arc discharge, laser ablation and chemical vapor deposition (CVD) systems. Flame
synthesis uses a carbon-rich flame to produce CNTs when a metal catalyst is introduced
into the system [49]. In the arc discharge method an arc is formed between two graphitic
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electrodes (anode and cathode) in a gas atmosphere (usually argon or hydrogen). During
the process the carbon is evaporated and consequently condenses forming fibrous mate-
rial on the cathode surface. The obtained product usually consists mostly of MWCNTs.
SWCNTs can also be produced using arc discharge depending on the reaction parame-
ters such as the size of graphitic precursor [50] and catalyst choice. A common binary
catalyst for high yield SWCNTs is Ni-Y [51]. In addition, some graphitic material and
amorphous species are also present [52–54]. SWCNTs can be produced with this tech-
nique through the suitable addition of a metal catalyst in the [51]. In the laser ablation
method an intense laser beam is fired on to a target consisting of graphite doped with
metal catalysts which resides in a flowing inert gas atmosphere. The technique pro-
duces high yield SWCNT. Typically their diameter distribution is very small and can be
easily modified via the synthesis parameters [55–57]. By far the most popular method
to synthesize carbon nanotubes is the CVD route. In CVD usually a catalyst particle
is employed to nucleate and grow the carbon nanotubes as well as to help decompose
the carbon feedstock. Reaction temperatures vary between 300 and 1000 ◦C depending
on the chosen feedstock. The most utilized carbon sources are methane, cyclohexane)
[58, 59], alcohols (e.g. ethanol) [60–62], organometalic compounds (e.g. ferrocene) [63]
and carbon monoxide [64]. CNTs produced via CVD are often characterized by large
diameter distributions. The as-produced material also contains impurities such as cat-
alyst particles, amorphous carbon and encapsulated metal particles. Optimizing the
synthesis parameters can minimize impurities, but rarely, if at all, fully prevent their
formation. One example of this optimization for the high yield synthesis of SWCNTs
was shown by Hata et al.[65]. They demonstrated a water-assisted CVD route argued
to yield a product consisting of 99,98 % SWCNTs. The use of CNT in biomedical
applications requires they be of high purity with well defined properties. To achieve
this, purification steps are needed. To this end, numerous methods have been elabo-
rated. Carbonaceous impurities are usually removed by oxidation in fixed air or oxygen
at ∼ 300 ◦C [66–71]. Other oxidizing methods apply oxidizing agents, e.g. nitric acid,
aqua regia or potassium permanganate, using reflux or microwave digestion treatments
[66, 72]. The oxidation processes can open the ends of closed tubes, since the greater
curvature of end caps makes them more reactive. In addition, the purification routes
usually lead to surface functionalization. Impurities like metal catalyst or support mate-
rials are usually removed by acid treatments (e.g. hydrochloric, nitric, sulphuric acid or
acids mixtures). Essentially the acid or acids applied dissolve unwanted material which
can then be easily washed away [66, 67, 72–75]. Ultrasound treatments are sometimes
employed in order to disperse the CNT, to cut them (shorten) and accelerate dissolution
[72]. Once purified, the nanotubes are ready for further functionalization, for example,
to make them biocompatible. The relatively large surface area and hollow core found
with carbon nanotubes allow them to be functionalized in two basic ways. In the first,
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the exceptional ability of sp2 carbon to form bonds with different materials is exploited
e.g molecules are attached to the outer surfaces of the tubes and this type of function-
alization is referred to as exohedral functionalization. The second route, endohedral
functionalization, takes advantage of the tubes hollow interior. Within the context of
biomedical applications the demand for functionalized CNTs is to develop them into vi-
able platforms for specific cell or tissue targeting, tracking or imaging and therapeutics.
Various strategies to exohedrally functionalize CNTs have been designed to make them
biocompatible [76, 77]. Two basic approaches are adopted: non-covalent and covalent
functionalization. The non-covalent functionalization routes involve the preparation of
a stable dispersion by coating the CNTs surfaces with molecules (e.g. copolymers, lipid,
surfactants, DNA) [78–82]. For example the use of synthetic tocopheryl polyethylene
glycol succinate (TPGS) molecules was shown to disperse MWCNTs effectively at mass
rations (TPGS:MWCNTs) 1:4 or greater[83]. The covalent functionalization of tube
surfaces is typically realized through cycloaddition reactions which attach ammonium
groups or via strong acid treatment to generate carboxylic acid groups [77]. Non-covalent
and covalent functionalization offer well dispersed, flexible carbon nanotube platforms
suitable for further derivatization e.g. loading with anti-cancer drugs. The loading of
various anti-cancer drugs have been demonstrated to date. An example is folic acid
antagonist methotrexate (MTX) which is toxic and has limited cell uptake. MTX can
be covalently connected via different linkers (like cleavable linkers) to carbon nanotubes
[84]. The cytotoxic activity is strongly dependent on the type of linker used for the func-
tionalization. Other popular anti-cancer drugs loaded through surface functionalization
are doxorubicin (DOX) [80, 85], 10 hydroxycamptothecin (HCPT) [86], paclitaxel (PTX)
[87] and cisplatin [88]. Prior to loading the CNTs are dispersed in aqueous solution, for
example, tri-block copolymer Pluronic F127 [80], or through covalent functionalization
with polyethylene glycol (PEG), or non-covalently with a phospholipid (PL)-PEG sur-
factant [85]. The release of these drugs strongly depends on the diameter of the CNTs.
This is due to the more efficient π-stacking of aromatic molecules on bigger nanotubes
(flatter). Hence, for larger tubes drug release is less effective. Additionally, molecular
targeting agents for cancer cells like e.g. biotin [89], cyclic RGD (Arg-Gly-Asp) pep-
tide [51] can be successfully connected on tube surfaces. This helps the functionalized
CNT reach cancerous cells more accurately. As mentioned previously, carbon nanotubes
can be also functionalized endohedrally. The placement of therapeutic molecules within
tubes can be advantageous. For example, enclosure within the core can protect molecules
sensitive to photo-degradation. One of the simplest ways to fill CNTs is to use capil-
larity, which is a process in which liquid spontaneously enters a narrow space and is
due to inter-molecular attractive forces between the liquid and surrounding surface of
the solid (the nanotube). Using this phenomenon via wet chemistry various anticancer
therapeutics can be loaded in the tube interior. Carboplatin [90] or cisplatin [91, 92] can
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be loaded by mixing with dispersed CNT in dimethylforamide and stirred over a period
of time. Thereafter the mixture is filtrated and excess of therapeutic material is rinsed
off. The encapsulation of ferromagnetic materials (e.g. iron) inside CNTs are important
for hyperthermia treatments [84, 93]. Filling the tubes with ferromagnetic metals can be
achieved through a variety of routes. The filling can be obtained simultaneously during
the synthesis of the carbon nanotubes [84, 94–102]. They can be filled via wet chemistry
procedures (e.g. Figure 2.5A) [103] or by hot vapor filling using organometallic com-
pounds such as ferrocene, cyclopentadienliron dicarbonyl dimer [104]. The Figure 2.5B
shows the various possibilities of functionalization of CNTs.
Figure 2.5: A. Transmission electron micrograph of an Fe-filled MWCNT.
(Sample courtesy S. Hampel) B. Schematic highlighting the versatile functionalization
possibilities of carbon nanotubes.
With regards their toxicity there is still no clear evidence of the toxic influence of carbon
nanotubes in biomedical applications. Studies on non-functionalized carbon nanotubes
dispersed in different solutions with different concentrations [105–108] have been con-
ducted. The results are somewhat unclear, in that some suggest serious health risks
associated with carbon nanotube exposure. Most investigations are based on CNT en-
try through the pulmonary route. However, the relevance of these studies is limited when
considering biomedical applications because the dosing and administration parameters
used are not applicable in this context [76]. Recently Kagan et al. [109] showed a novel
enzymatic biodegradation route of SWCNTs relevant to respiratory exposures through
the neutrophil enzymatic system. The study pointed out that the doses of nanotubes
used in the toxicity tests might be too high, overwhelming the degradation capacity of
this enzymatic system. Some studies indicate CNT length dependencies. Long and stiff
carbon nanotubes (≥10 µm) can accumulate in tissues and trigger cancer e.g. mesothe-
lioma [110, 111]. Studies on lipopolymer or surfactant coated CNTs show that they tend
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to accumulate in the liver and cannot be metabolized there [112–114]. However, the use
of short and functionalized carbon nanotubes (≤1 µm) suggest an improved toxicolog-
ical profile [115]. CNTs with small dimensions which are short and well dispersed in
the body do not accumulate in tissue and are easily removed through urinary excretion
[116–119].
2.3.3 2-Dimensional carbon nanoparticles
The concept of a two-dimensional (2D) carbon nanoparticles was introduced after the
graphene was first isolated in 2004 by Geim and Novoselov [120]. Graphene (Figure 2.6A)
is essentially an isolated atomic plane of graphite. It has exciting physical properties
such as high mechanical stiffness [121, 122] and excellent electronic transport properties
[120, 123]. Recently studies have begun to exploit the potential of nano-sized pristine
graphene and in its oxidized form (NGO). NGO (Figure 2.6B) is also a two-dimensional
(2D) material, which is derived from graphene. It is mainly produced from the oxidative
treatment of graphite via three main methods [124] developed by Brodie [125], Hummer
[126] and Staudenmaier [127]. Due to its increased biocompatibility properties it is
thought to be used for biological applications. This includes their potential as drug
delivery systems (DDS) [128, 129] and, for cellular delivery of genes and peptides or
proteins [130].
A B 
Figure 2.6: A shows represents a single layer of graphene. B represents the graphene
with its oxidized basal plane and edges.
Future biomedical applications of the graphene family may also include implantable sen-
sors, tissue scaffolds or coating prosthetics and implanted devices [131]. As mentioned
before, the most used form of graphene in the biomedical field is the NGO. The most
frequently adopted approach to prepare this material is by the Hummers method; Ini-
tially the graphite is oxidized using a KMnO4/H2SO4 mixture. Nanosizing the GO is
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usually accomplished by ultrasonication. Ultracentrifugation is then employed to sepa-
rate the nano-sized sheets (less than 10 nm) from larger ones [128–130, 132, 133]. NGO
prepared in this form is easily soluble in water, due to the presence of functional groups
e.g. hydroxyl groups (–OH), epoxide (R-CH-O-CH2) and ester groups (R1-COO-R2),
keton groups (C=O), and carboxylic acid groups (–COOH) on its surface. In order to
prepare the structures for biofunctionalization the epoxy and ester groups need to be
converted to hydroxyl groups and subsequently to carboxylic acid moieties (–COOH).
This is achieved by adding chloroacetic acid under strong basic conditions to the NGO-
water solution [133, 134]. The NGO now rich with carboxylic acid groups can be sub-
sequently functionalized with a biocompatible polymer like polyethylene glycol (PEG)
– pegylation [132, 133]. PEG is a particularly attractive polymer for conjugation with
specific moieties, as it provides good water solubility, high mobility in solution, is not
toxic and does not lead to immunogenicity. Moreover, it can readily be cleared from
the body and also offers altered distribution in the body. These properties are all im-
portant aspects for bio-applications. The introduction of sulfonic acid groups is another
functionalization route for stable dispersion in physiological solutions [128, 135]. At this
stage the NGO can be loaded with anticancer drugs via non-covalent bonding for tar-
geted drug delivery. Because anticancer drugs are usually water insoluble, NGO is an
attractive platform to overcome this drawback. Doxorubicin (DOX) or/and Irinotecan,
or Gefitinib are commonly used as model anticancer drugs for application with NGO
[128–130, 132, 133]. Doxorubicin is commonly used to treat some leukemias, Hodgkin’s
lymphoma, as well as cancers of the bladder, breast, stomach, lung, ovaries, thyroid,
soft tissue sarcoma, multiple myeloma, and others [136]. Irinotecan is a semisynthetic
analogue of the natural alkaloid camptothecin. Its main use is in colon cancer, particu-
larly in combination with other chemotherapy agents [137]. Gefitinib is currently only
employed for the treatment of locally advanced or metastatic non-small cell lung cancer
(NSCLC) in patients who have previously received chemotherapy [138]. In addition, to
improve targeting, additional molecules like folic acid (FA) (to target cells with folate
receptors) [128], or antibodies, e.g. Rituxan (a B-cell specific antibody to selectively
recognize and bind to B-cell lymphoma cells) can be covalently conjugated. Important
results from cytotoxicity tests performed on pristine NGO and on functionalized NGO
(e.g. NGO-PEG) have been conducted. They show that prior to drug loading they are
practically non-toxic, even at very high concentrations (more than 100 mg/L) [133].
2.3.4 3-Dimensional carbon nanoparticles
The concept of a 3-dimensional carbon nanostructure was introduced by the production
of empty multi-layered graphene shells. A lot of interest in 3D graphene objects is
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related also to the possibility of surface functionalization or filling emptyfied cores (e.g.
with functional groups, metals or drugs for biomedical applications) in order to use the
material for different variety applications. In Figure 2.7 it is possible to see a chemical
representation of the graphene nanoshells.
Figure 2.7: Cross section of a structural representation of the graphene nanoshells.
The graphene layers are concentrically arranged forming a hollow spherical structure.
The easiest way to form three-dimensional graphene structures is connected with their
synthesis over specific nanoparticles. There are three main types of the nanoparticles
which can be used as such a templates, namely: metals [139], oxides [140, 141] and car-
bides [142]. Metals and oxides based structures have big advantage over carbide based
structures which is related to the ease of removal of the core by simple wet chemistry
methods (e.g. dissolving by acids), whereas carbides are not so easy to eliminate from
the graphene coated objects. Utilization of metal nanoparticles like e.g. nickel brings
relatively cheap method of creating graphene coated 3D core shell nanostructures by car-
burization process, where the metal cores can be further eliminated via e.g. hydrochloric
acid removal [139]. However, in case of metal nanoparticles removal there is always a
risk of metal remains presence in the sample after purification process, therefore oxide
nanoparticles have superiority over metal nanoparticles for preparation of 3D graphene
which is related to obtaining fully metal free carbon structures.
2.3.5 Metallic nanoparticles coated with graphene
Carbon-encapsulated metallic nanoparticles (CEMN) are core-shell structures, mostly
spherical in shape with diameters ranging from a few nanometers up to tens of nanome-
ters (Figure 2.8). Their core consists of a nanosized metal or metal oxide particles (e.g.
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iron, cobalt, nickel or iron-cobalt alloy, iron oxides) and their shell is comprised of several
graphitic layers [143–151].
Figure 2.8: Representation of a carbon-encapsulated metallic nanoparticle.
CEMN are usually produced by arc discharge [144], thermal plasma synthesis [143, 152]
or via the thermal decomposition of compounds containing the required metal [147,
153]. The cores of the carbon-encapsulated magnetic nanoparticles are sensitive to
magnetic fields, thus apart from their potential as drug carriers [154] they also hold
promise as contrast agents in magnetic resonance imaging (MRI) [155] and anti-cancer
hyperthermia treatments [147]. The graphitic coating layers range from 1 up to 40
layers and play several important roles; to protect inner particle from the oxidization,
to isolate the magnetic nanoparticles from each other and to provide biocompatibility
as well as afford the surface functionalization with antibodies, proteins, medical drugs,
etc. for extended bio-applications. Usually the as-produced material contains unwanted
species (impurities) such as amorphous carbon, uncoated metal or metal oxide particles,
graphitic nanoparticles, unfilled graphitic capsules, carbon nanotubes, carbon fibres[143,
144, 147, 153]. Carbonaceous impurities can be easily removed through post-synthesis
treatments. Examples include oxidation in air at ∼ 300 ◦C, or exposure to oxidizing
agents like hydrogen peroxide. Unwanted metal and metal oxides species are commonly
removed through acid treatments (e.g. hydrochloric, nitric or sulphuric acid) [143, 144].
In addition, centrifugation steps can be used in order to separate (by mass) unfilled
graphitic capsules from the heavier filled particles. After the purification procedures
the carbon encapsulated magnetic nanoparticles are then prepared for biocompatibility
through surface functionalization. This step is often accomplished by first oxidizing
their surface in hot acid solutions (e.g. nitric acid or sulphuric acid, or their mixtures)
[154, 156]. The oxidation process forms carboxylic groups (–COOH) on the surface of
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the particles. These groups enable further functionalization by conjugation with amino-
containing molecules via diazonium chemistry [157], amidation [158] or diimide-activated
amidation [159]. The resultant surface functionalized encapsulated nanoparticles are
intermediates that can be yet further functionalized (Figure 2.9). For example amine
reactive intermediates can react with the carboxylic groups of biomolecules, e.g. proteins
and form stable amide bonds. These can be further functionalized for biocompatibility.
Figure 2.9: Illustration representing a functionalized encapsulate.
This is often accomplished with poly(ethylene glycol) – PEG [151]. PEG functional-
ized carbon-encapsulated magnetic nanoparticles are stable against aggregation under
physiologically relevant conditions, are undetectable to the immune system and can be
addressed to specific regions of the body. Moreover, in vitro and in vivo toxicity assays
show no obvious cytotoxicity from these nanostructures and no obvious negative health
problems for the tested organisms over a monitoring period ca. 6 months [151]. In ad-
dition, the nanoparticles remain stable in blood circulation for over 20 minutes, which,
in this sense, makes them superior than standard MRI contrast agents.
2.3.6 Other carbon allotropes
2.3.6.1 Carbon nanohorns
Single-walled carbon nanohorns (SWCNHs) were originally fabricated by Iijima in 1999
[160]. They are horn shaped nanostructures (average cone angle 120◦) composed of sin-
gle graphene sheets with lower diameters of around 2 nm (Figure 2.10). They usually
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form aggregates with diameters ca. 80 nm with a “dahlia-like” petal shape. The syn-
thesis of single-walled carbon nanohorns is usually through CO2 laser evaporization of
graphite target at room temperature in a buffer gas (Ar, He, N2) at pressures ranging
from 200 to 1000 mbar [161, 162]. The as-produced material consists predominantly
of SWCNHs. A small quantity of amorphous carbon is also present. The properties
of SWCNHs are similar to carbon nanotubes, thus they are easily functionalized (e.g.
fluorination, amidation) [163–166], solubilised and dispersed in water or physiological
solutions following similar techniques used with CNTs.
Figure 2.10: Illustration representing a single-walled carbon nanohorn.
2.3.6.2 Nanodiamonds
Nanodiamonds (NDs) were first discovered in 1963 by K. V. Volkov during diamond
synthesis studies through shock compression in a blast chamber [167]. NDs are nano-
sized particles with diameter smaller than 10 nm (Figure 2.11).
They can be synthesized with a good yield and quality via the detonation of certain
explosives in a closed chamber [168–171]. Other synthesis methods like chemical vapor
deposition [172, 173] or shock compression of graphite [174] provide particles with large
grain size or polycrystalline diamond films. The as-produced material, whilst mostly con-
sisting of NDs, often also contains unwanted amorphous, graphitic and metallic species.
Metal particles are commonly removed by acid treatment e.g. H2SO4, HNO3 or mixtures
[175, 176]. To remove carbonaceous impurities different oxidative treatments can be ap-
plied, e.g. in solutions: KOH/KNO3, Na2O2, CrO3/H2SO4, and HNO3/H2O2 under
pressure or oxidation in air at ca. 400 ◦C [177–179]. A promising route is based on an
autoclave method using HNO3/H2O2, where at high temperature, ca. 280
◦, unwanted
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Figure 2.11: Illustration representing the structure of a nanodiamond.
carbon species are dissolved and transformed into gaseous form without any other par-
ticles forming during the process [175]. In addition, any metal impurities present are
easily dissolved and washed away. Nanodiamonds are characterized by low solubility
in most solvents [160]. Hence, for bio-applications they must undergo surface function-
alization [180–183]. Their surface can be functionalized with hydroxyls, carboxylics,
ketones or amine groups which prepare them for further use in dispersions in aqueous
or physiological solutions [184]. In order to improve solubility and biocompatibility of
NDs they can be additionally covalently functionalized via diazitozation with diazonium
salts [183], fluorination [182], chlorination, silynation [183]. Non-covalent functionaliza-
tion with organic and biological molecules like luciferase [185] and lysozyme [186] enables
such functionalized NDs to serve as biomarkers. Small amounts of anticancer drugs like
doxorubicin or paclitaxel ( 25% of NDs mass) can be loaded on their surface when
functionalized with –NH2 groups. This makes them relevant for future drug delivery
[187]. Nanodiamond particles can be successfully used as magnetic resonance imaging
markers after covalently functionalizing them with –COOH groups on their surfaces
with an amine functionalized gadolinium (III) complex [188]. Moreover, when prepared
in a fluorescent-magnetic form they can be used as cellular fluorescence markers [189].
To make them fluorescent NDs powder is first mixed with ferrocene and silicon pow-
der and then treated in a microwave arcing process. The resultant material consists of
iron nanoparticles connected with NDs and graphene sheets, and is in essence a new
nanocomposite material [190, 191]. Next, fluorescent moieties are covalently attached
to the previously formed magnetic NDs forming fluorescent magnetic nanodiamonds
(FMNDs) via the surface attachment of poly(acrylic acids) and fluorescein o-methacrylate.
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The fluorescent-magnetic NDs are water soluble and can be successfully used for fluo-
rescence imaging of cells (e.g. HeLa cells) [189]. NDs also exhibit a degree of natural
fluorescence [192]. In vitro experiments with different cell lines using both functionalized
and unfunctionalized NDs showed practically no toxicity [187, 193–195]. Additionally,
in vivo (mice) studies showed no allergic response upon contact with skin to be induced
[187].
2.4 Summary
Nanotechnology is very diverse and holds much promise in many fields. At the same
time there exists significant debate on the future implications of nanotechnology. Within
medicine, nanotechnology provides cause for much excitement. It could potentially offer
diagnosis and therapy tailored to patients. Moreover, it could be delivered with unprece-
dented precision. With these goals in mind, carbon nanostructures are being actively
explored as supportive substrates as well as excipients for multi-functional drug delivery
systems. Such systems are highly relevant in future strategies to combat and ultimately
cure cancer. Current cancer treatments include surgery, radiation and chemotherapy.
Although they can claim a degree of success, these approaches also kill healthy cells and
cause toxicity to the patient. In addition, there are difficulties in the administration
of drugs, such as insolubility of drugs, inefficient distribution, lack of selectivity and
side-effects. In drug delivery, cell membranes also pose a problem by selectively allowing
only certain structures to pass depending on their hydrophilicity. Great efforts are be-
ing made to develop novel cancer strategies that directly target cancerous cells without
affecting healthy ones. These strategies should offer improved efficiency, viability and
toxicity profiles. Carbon nanostructures are amongst the leading contenders because
their physicochemical properties offer both covalent and noncovalent functionalization
with disparate functional groups. Moreover they can carry several moieties and in some
cases provide enclosed payload options. They can also passively cross the membranes
of many different types of cells [196]. These features make them ideal building blocks
for targeting, imaging and multi-therapy systems. The versatility of carbon nanostruc-
tures to combat numerous diseases as well as provide diagnostic ability are highlighted
in Table I in which different carbon nanostructures functionalized in various manners
are applied to a multitude of therapeutic approaches.
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Chapter 3
Techniques
The third chapter of this work is divided into 3 parts and it is aimed to (1) describe
the main techniques used to synthesize the iron oxide nanoparticle and the graphene
oxide nanoparticles; (2) present the main techniques used in this work to characterize
the as-synthesized nanostructured materials. And (3) present the biological approaches
used to investigate the interaction between the nanoparticles and biological cells.
3.1 Synthesis techniques
There are three primary techniques used to synthesize carbon-based nanostructures:
chemical vapor deposition, arc-discharge and laser ablation. Colloidal chemistry is also
a method that allows synthesis of nanoparticles. This technique was the main pro-
cess used to synthesize iron oxide nanoparticle, since it allows the production of nearly
monodispersed size distributions of nanoparticles. In this work, we also observed that
the colloidal chemistry route showed to render nanoparticles with both amorphous and
graphitic coatings. This method is suitable to produce large amounts of nanoparticles.
The nanographene oxide nanoparticles were also produced using a chemical approach.
This chemical procedure is called Hummers method and is also suitable to render large
amounts of material. All these techniques are briefly described in the following four
subsections.
3.1.1 Colloidal chemistry
A colloid is one of the three main types of mixtures, with the other two being a solution
or a suspension. A colloid is a solution which contains particles ranging from 1 nm
to 1 µm in diameter and yet is still able to remain evenly distributed throughout the
27
Chapter 3. Techniques 28
solution. These can also be called colloidal dispersions because the dispersed substance
(colloidal particles) does not precipitate to the bottom. A colloid is can be prepared in
two ways: (1) by reducing large particles to the colloidal size or (2) by increasing small
particles (usually single molecules) to the size of colloidal particles. The first method
can be achieved by turning large particles to colloidal dimensions by milling, spraying or
application of shear. Whereas in the second method, small particles or molecules reach
the colloidal dimensions by merging with one another, condensing or redox reactions.
This second approach is used in this work to form iron oxide nanoparticle from iron
oleate molecules [228]. The precise experimental process is described later in chapter 4.
3.1.2 Chemical vapor deposition
The growth process using chemical vapor deposition (CVD) involves heating catalyst
materials to high temperatures (500 – 1000 ◦C) in a furnace and flowing catalyst solutions
through the tube reactor under low or atmospheric pressure for a period of time [229].
The CVD device is composed of three different parts: an aerosol generator, a quartz
reactor placed in a furnace and traps for the exhausting gases. Figure 3.1 illustrates the
equipment set-up.
Figure 3.1: Illustration of a CVD apparatus.
This CVD set-up is one of the most commonly used method to synthesize MWCNTs,
metallic-filled MWCNTs and metallic nanoparticles coated with graphene. The growth
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of different types of carbon nanostructures is highly dependent on the synthesis param-
eters. It is generally accepted that the hydrocarbon source or catalyst solution is turned
into aerosol and transported by the carrier gas to the quartz reactor inside the furnace.
Due to the high temperatures it dissociates resulting in free carbon atoms [229, 230].
Inside the furnace, the high activity of carbon in the gas phase drives carbon to dissolve
in the nano-sized metal catalysts particles. These particles get saturated with carbon
and their precipitation leads to the formation of tubular carbon structures. Simultane-
ously, during the CNTs growth, catalysts particles can continuously accumulate at the
exposed ends [231, 232]. Most of CVD synthesis processes use metals as catalysts to
grow carbon nanostructures; usually iron (Fe), cobalt (Co) and nickel (Ni) is used to
produce CNTs, however other elements such as Aluminum (Al), Gold (Au), Molybde-
num (Mo) can also be used. For the MWCNTs growth, the catalytic decomposition of
hydrocarbon gases such as acetylene, ethylene, xylene or benzene on catalytic metal is
required. The growth of SWCNTs is also possible using the CVD process, however it is
still being actively developed by many researchers [233]. The CVD has established itself
over the last years as the main synthesis method for carbon nanostructures. This method
provides material of good quality with relatively low cost and can be easily scaled up.
In other words, it provides a relative control of nanoparticles during growth, allowing
in this way a selectively growing e.g. at specific locations and directly building highly
organized CNTs structures, which is impossible with the other two methods described
that will be described.
3.1.3 Arc-discharge
The arc-discharge method is also used to produce carbon nanostructures, especially both
single- and multi-walled carbon nanotubes. It consists of two graphite rods (anode and
cathode) which are generally used as electrodes and the Helium (He) or Argon (Ar)
gas is used for inert atmosphere conditions. As the rods are brought close together, a
discharge of approximately 20 – 35 V is applied, resulting in the formation of plasma,
where the temperature is close to 3500 ◦C. Thus, the anode is consumed by plasma
and ionized carbon atoms are attracted to the graphite cathode. Rod-like deposits are
formed on this electrode and the multi-walled carbon nanotubes can be collected in the
core of the deposits. It is also important to mention that this method also produces
other graphitic species such as fullerenes and amorphous carbon. Figure 3.2 shows a
simplified sketch of an arc-discharge device [233].
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Figure 3.2: Illustration of an arc-discharge apparatus.
3.1.4 Laser ablation
Laser ablation is another stablished technique mainly used in yielding high-quality SWC-
NTs. This method also led to the discovery of fullerenes [234]. In this method, a carbon
target containing a metallic (metal-graphite composite target) is mounted in a high-
temperature furnace and intense laser pulses are used to ablate the target under inert
conditions such as an atmosphere with Helium (He), Argon (Ar) or Nitrogen (N). The
laser vaporization is swept by the gas flowing from the high-temperature zone, and de-
posited onto a water-cooled copper collector positioned downstream, just outside the
furnace [233]. In contrast with the CVD method, the laser ablation technique cannot
be done at low cost due to the high cost of special lasers. Figure 3.3 shows a simplified
sketch of the laser ablation set-up.
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Figure 3.3: Illustration of a laser ablation apparatus.
3.1.5 Hummers method
The Hummers method is widely used to produce graphene oxide using graphite as a
starting product. In this method, the oxidation of graphite to graphitic oxide is ac-
complished by treating graphite with concentrated sulfuric acid, sodium nitrate and
potassium permanganate. In a typical experiment the graphite is stirred with sulfuric
acid and sodium nitrate. This process is done in a cooled (around 0 ◦C) ice bath and
maintained in vigorous agitation for about 30 minutes. Afterwards the potassium per-
manganate is added gradually. After a series of rinsing and filtration steps it is possible
to obtain oxidized graphite. The detailed experimental procedure to produce nano-sized
graphene oxide flakes will be described in greater detail in chapter 4.
3.2 Characterization techniques
The synthesized carbon nanostructures were all thoroughly characterized and analysed
using various techniques. In order to make it more comprehensive, the techniques used
in this work were divided into different sections (microscopy, spectroscopy, magnetic and
biological) and briefly described.
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3.2.1 Electron microscopy
3.2.1.1 Scanning electron microscopy
The scanning electron microscope (SEM) was invented by Manfred von Ardenne in 1937
and proposed different detection modes, possibilities and theory of SEM [235, 236]. The
SEM produces images by scanning the sample with a focused electron beam. These
electrons interact with the atoms in the surface of the sample and produces different
signals, which contain information about the samples topography and composition. The
most used mode to acquire image is by detecting the secondary electrons (SE) emitted
by the atoms of the sample, which were excited by the electron beam. The SEM can
also produce back-scattered electrons (BSE) and characteristic X-rays. The BSE are
electrons that are reflected from the sample by elastic scattering. The BSE signal is
related to the atomic number of the specimen and therefore this singal can be used to
provide information about the elemental distribution in the sample. The characteristic
X-rays are emitted when the electron beam remove electron from the inner shell of the
atoms of the sample. The characteristic X-rays are also used to make elemental mapping
of the sample. In Figure 3.4, it is possible to see a sketch of the main different electron
interactions with the sample and the excitation volume.
Figure 3.4: In A it is possible to see what is the result of the interaction of the primary
electron beam with the sample and in B it is showing the excitation volume.
3.2.1.2 Transmission electron microscopy
The idea of an electron microscope was first proposed in the paper written by Knoll
and Ruska in 1932 [237]. In their work they presented the concept of electron lenses
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in practical reality and demonstrated that electron images could be taken. However,
currently the basic design of a modern TEM roughly follows the initial design proposed
by its inventors. The transmission electron microscope (TEM) uses a beam of electrons,
which is transmitted through a transparent sample (thickness in nanometric range and
not thicker than 100 nm). The electron beam from the electron source is collimated
and interacts with the sample and passing through it. The image is formed from this
interaction of the transmitted electrons through the sample. The image is then magnified
onto a fluorescent screen or can be detected by a sensor such as a CCD camera. The
TEM allows imaging at very high resolution due to the small de Broglie wavelength of
electrons. A simplified image of a TEM is shown in Figure 3.5.
Stage 
(Sample) 
Electron source 
SA aperture 
Phosphor screen 
Objective aperture 
Diffraction aperture 
Binacular 
Condensor apertures Objective lens 
Projector lens 
Diffraction lens 
Intermediate lens 
CCD Detector 
Figure 3.5: Simplified illustration of TEM.
Together with a TEM it is possible to install a detector for energy-dispersive X-ray
spectroscopy (EDX). The EDX is a technique used for elemental analysis of samples.
In tis technique the focused electron beam shines onto the sample and stimulate the
emission of characteristic X-rays, which is unique for each specific element. This enables
one to make a chemical characterization of the material being studied. Another technique
that can be used with TEM and is complementary to EDX is the electron energy loss
spectroscopy (EELS). When a coherent electron beam shines onto a material it can
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undergo inelastic scattering. This means that the primary electron loses energy when
interacting with the sample and also scatters randomly from their initial path. The
amount of energy that the scattered electron loses can be measured using and electron
spectrometer and analysed in terms of what caused the energy loss. The EDX and EELS
are taken as complementary because while EDX is more sensitive to heavier elements,
EELS is more sensitive to lighter elements like Carbon and also has the advantage to
be able to probe different forms of the same element, e.g. differences between diamond,
amorphous carbon and graphite. The high resolution that can be achieved with TEM
is due to the use of high energy electrons (∼200 keV), which have a wavelength in
the picometer range. However the resolution of the microscope is limited by intrinsic
imperfections of electron lenses. These imperfections are referred as aberrations. These
aberrations are denoted as spherical and chromatic. These aberrations can be reduced
by installing different set of additional lenses which are called aberration correctors.
3.2.2 Scanning probe microscopy
The history of scanning force microscopy started with the invention of the scanning
tunneling microscope (STM) by Gerd Binnig and Heini Rohrer in 1982, where an atom-
ically sharp tip is placed sufficiently close to the surface of a conducting sample that
the tunneling of electrons is possible. The tunneling current as a function of position of
the tip across the sample provides an image that reflects the electronic structure of the
uppermost atoms at the surface of the sample. In other word, STM probes the density
of states on the surface of materials using the tunneling current in order to create a
topographic image. The atomically short depth of focus of the STM distinguishes it
from scanning or transmission electron microscopes. In addition, the atoms at the apex
of the STM tip exert a force on the surface of the sample which is of the same order of
magnitude as that of interatomic forces [238]. This new effect described above gave rise
to a novel direction when the first atomic force microscope (AFM) results were published
by Gerd Binnig, Calvin Quate and Christopher Gerber in 1986. For this, instead of us-
ing a tip whose direction is normal to the surface of the sample, they positioned it an
almost parallel direction so that its sharp edge was just above the surface. This position
of the STM tip, acting now as a cantilever, exerted force on the sample as well as the
vertical set-up did, however the deflections of the lever with its force-sensing edges were
of importance instead of the tunneling current [238]. Since then, AFM use has grown
exponentially and is being improved. Nowadays, it is one of the main techniques used
to probe surface topography and electrostatic and magnetostatic stray fields across a
surface. It is also being used to unravel the folding processes of proteins by measuring
the forces necessary to unfold them [239–241]. The AFM was used to measure the height
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of the nanographene oxide flakes, which allows the estimation of the number of layers of
the as-synthesized nanographene oxide.
3.2.3 Spectroscopy techniques
3.2.3.1 Raman spectroscopy
The Raman spectroscopy is a non-destructive tool used in industry and academia to
characterize and monitor a wide variety of materials. The technique was named after
Chandrasekhara Venkata Raman, who first described the inelastic scattering of light
[242]. When a monochromatic source of light with energy hυ0hits a molecule, a scat-
tering process happens. This scattering can be elastic (Rayleigh scattering) or inelastic
(Raman scattering). Therefore, the Raman spectroscopy is the technique that relies
on the transfer of vibrational energy of a monochromatic light source to the molecule.
The wavenumber position of the peaks of the Raman spectrum indicates the vibrational
states in the material while the width describes the molecular structure. The technique
basically consists of a laser source which is shone on the surface of a material. The
inelastic scattering is usually done by a photodetector, such as a charged couple device
(CCD), which records the intensity of the inelastic scattering in arbitrary units by wave-
length. In this work, the Raman spectroscopy is used to confirm the presence of the
sp2 carbon in the nanoparticle samples. This is done by the presence of the so-called
D and G modes in the Raman spectrum. The G-band (located at approximately 1600
cm−1) of the spectrum is an intrinsic feature of graphitic materials and is closely related
to the vibrations of the sp2 hybridized carbon. The D-band (located at approximately
1350 cm−1) is involved with the scattering from defects, which breaks the basic sym-
metry of the graphene sheets. The D-band can be easily seen in sp2 hybridized carbon
containing porous, impurities or other symmetry-breaking defects. A typical Raman
spectrum showing the D- and G-bands of a graphitic material is shown in Figure 3.6.
When single layer graphene is observed, the most obvious difference in the Raman spec-
trum in comparison to the multi-layered graphene (graphite) is the presence of a peak at
2700 cm−1, which is known as the 2D-band or also known as G’-band.
3.2.3.2 Fourier-transform infrared spectroscopy
The infrared (IR) spectroscopy is a technique that is often complementary to the Raman
spectroscopy when analysing materials. For a molecule to present infrared absorptions it
must possess an electric dipole moment, which must change during the molecular vibra-
tions. Hence, an infrared-active molecule (heteronuclear molecule) has a dipole moment
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Figure 3.6: Schematics illustrating the Raman spectrum containing the D- and G-
modes.
different from zero, whereas an infrared-inactive molecule (homonuclear molecule) has a
dipole moment that remains zero no matter how long the bond is. Figure 3.7 illustrates
the hetero- and homonuclear molecules.
The IR spectra are normally collected by measuring the transmittance of photons with
a continuous distribution of the sample. The frequencies of the absorption bands
are proportional to the energy difference between the vibrational ground and excited
states. The absorption bands are normally found to be in the wavelength region of
2.5 – 1000 µm. The Fourier-transform infrared (FTIR) is based on the idea of the inter-
ference of radiation between two beam generating an interferogram. This interferogram
is a signal produced as a function of the change of pathway between the two beams. The
two domains of distance and frequency are interconvertible by the mathematical method
of Fourier-transformation [242, 243]. In this work FTIR is used to characterize and study
the presence of functional groups present in the nanoparticles. Furthermore, this tech-
nique is used to confirm that the carbon-nanostructures were successfully functionalized
with the desired molecules.
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Figure 3.7: A. Different vibrational changes in the dipole moment of a heteronuclear
molecule and in a B. homonuclear molecule.
3.2.3.3 X-Ray photoelectron spectroscopy
The X-ray photoelectron spectroscopy (XPS) was developed by Kai Siegbahn [244, 245]
in 1957. The technique is taken as one of the most important techniques to obtain infor-
mation of the electronic structure of matter. This is achieved through the relationship
of the photoelectric effect
I = hυ − Ee (3.1)
where I is the ionization potential or binding energy for an electron attached to an atom
or molecule, hυ is energy of the incident photon. The Ee is the kinetic energy of the
ejected electron, which can be measured with precision. In this way, the binding energy
can be determined. The XPS is also a powerful technique used to provide information
about the state and environmentof atoms in the sample, which can be used to obtain
information about the surface structure of the studied material. This is particularly im-
portant in carbon nanostructures because these materials can be functionalized in many
Chapter 3. Techniques 38
different ways and these functionalizations render carbon nanostructures new proper-
ties, which need to be addressed prior to the final application. Therefore, this technique
was also used to determine the presence of functional groups on the graphene oxide
nanoparticles.
3.2.4 Magnetic characterization
3.2.4.1 Vibrating sample magnetometer
A vibrating sample magnetometer is an instrument invented by Simon Foner at Lincoln
Laboratory in MIT that measures magnetic fields. In order to measure magnetic fields, a
sample is placed inside a uniform magnetic field. The sample is then vibrated through the
use of piezoelectric material. If the sample is magnetic, this uniform external magnetic
field will magnetize it by aligning the magnetic domains or individual magnetic spins with
this external field. The magnetic dipole moment of the sample will create a magnetic
field around the sample (stray magnetic field). As the sample vibrates up and down,
this magnetic stray field is changing in time and can be detected by a set of pick-up
coils. The alternating magnetic field will generate an electric current in the pick-up coils,
according to the Faraday’s law of induction, which is proportional to the magnetization
of the sample. This electric current is amplified by a transimpedance amplifier and
lock-in amplifier [246]. The VSM was used to acquire hyteresis curves of the magnetic
samples at room and low temperatures, as well as measure the magnetic behavior of the
nanoparticles and their dependence of temperature
3.2.4.2 Superconducting quantum interference device
The superconducting quantum interference device (SQUID) is a very sensitive magne-
tometer and used to measure magnetic behavior of materials. The SQUID is based on
superconducting loops containing Josephson junctions [247]. The magnetic signal of a
magnetic sample is acquired through a superconducting pick-up coil. This coil is, to-
gether with a SQUID antenna, part of a superconducting circuit transferring magnetic
flux from the sample to the SQUID device which is located away from the sample in a
liquid helium bath. This device acts as a magnetic flux-to-voltage converter. This volt-
age is then amplified and read out by the magnetometer electronics. When the sample
vibrates up- and downwards it produces alternating magnetic flux in the pick-up coil
which leads to an alternating output voltage. By locking the frequency of the readout to
the frequency of the sample oscillation, the magnetometer system is sensitive to detect
ultra small magnetic signal in the order of 10−8 emu or 10−11 J/T.
Chapter 3. Techniques 39
3.2.4.3 Hyperthermia
The effect of heat in treating cancer has been known for decades and molecular mech-
anisms involved in the process are already understood. The term hyperthermia refers
to the artificial elevation of the temperature of target tissue to temperatures of about
41 ◦C [248]. The high temperatures achieved changes many of the structures and func-
tions of proteins and enzymes in the cell, which alters cellular growth and functions.
This alteration in cellular function induces apoptosis (cell death). When the temper-
ature used in the treatment of the target tissue reaches temperatures above 46 ◦C,
it is called thermoablation and leads to different cytotoxic effects. Although success-
ful clinical trials have been already conducted, thermoablation is not yet established
as a clinical routine [249]. As mentioned in chapter 2, magnetic nanoparticles have a
wide application potention and are already used in clinical routine as contrast agents in
magnetic resonance (MRI) [250]. The use of alternating magnetic fields to elevate the
temperature is denoted magnetic hyperthermia. Experiments using hyperthermia have
been performed since 1960, but the use of magnetic nanoparticles for heating purposes
was comprehensively studied by Jordan et al. only recently in 1993 [249] using super-
paramagnetic particles. The heating power of the particles is quantified as the specific
absorption rate (SAR) and describes the energy amount converted into heat per time
and mass, and its unit is given by [W/s]. The SAR is determined using the initial slope
of a temperature-time curve and is defined by equation 3.1 [249, 251, 252], where c is
the specific heat capacity, which in the case of water is c=4.118 J.g−1.K−1 and mact is
the mass of magnetically active material
SAR =
c
mact
(
dT
dt
)
t−→0
(3.2)
The heating process using an alternating magnetic field may be related to several phys-
ical mechanisms. The magnetic loss process is associated with the hysteresis occurring
during the reversal of the magnetization [253]. In systems of magnetic particles the en-
ergy is absorbed from an alternating magnetic field and is transformed into heat via: (1)
reversal of magnetization inside the crystalline structure of the particle [Néel relaxation]
or (2) rotation of the magnetic particle in a fluid suspension relative to the surroundings
(Brownian relaxation) [249, 253]. The heating phenomenon can also occur due to the
eddy currents, which is normally not desired. Eddy currents are a consequence of the law
of induction, which is not restricted to magnetic materials. This process, however, pro-
vides a significant heating effect only in electrically conducting materials of macroscopic
sizes. Therefore, the heating cause by this process is irrelevant when using nanoparticles
[253].
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3.2.5 Biological characterization
Before starting to describe the techniques used in this work to measure biological re-
sponses, it is important to briefly describe the main characteristic of a mammalian cell
and more importantly which cellular structures are responsible for these responses. The
cell is the basic structural, functional and biological unit of all living organisms. They are
classified into two categories: eukaryotic cells (which contain a nucleous) and prokary-
otic cells (which do not contain nucleous). The prokaryotic cells are simpler and smaller
than the eukariotik cells and lack of membrane-bound organelles (e.g. bacteria). The eu-
karyotic cells (e.g. plants, animals and fungi) are much bigger than typical prokaryiote,
but the most important feature that distinguishes eukaryotes from prokaryotes is com-
partimentalization, or in other words, the presence of membrane-bound compartments
in which specific metabolic activities take place. These specific membrane-bound struc-
tures are called organelles, analogous to the organs of the human body, but carrying
out one or more vital functions in the cellular level [254]. There are several types of
organelles (Figure 3.8) and each one has specialized function(s) as briefly described. In
this work we will be acquiring information only on the functioning of mitochondria and
cell membrane. These biological information can be obtained by specific assays. In this
work, we used the MTT and the Trypan blue assays to access information on how toxic
the nanoparticles are to the cells.
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Figure 3.8: Typical eukaryotic cell. The main cellular structure and organelles are
depicted. 1. Nucleolus (RNA production). 2. Nucleous (DNA maintainace, RNA
transcription, control all activities of the cell). 3. Ribossome (represented by the small
dots are responsible for translation of RNA into proteins). 4. Vesicles (material trans-
port). 5. Rough endoplasmic reticulum (translation and folding of proteins). 6. Golgi
apparatus (sorting, packing, processing and modification of proteins). 7. Cytoskeleton
(cellular shape, cell division). 8. Smooth endoplasmic reticulum (expression of lipids).
9. Mitochondria (energy production and release in the form of adenosine triphosphate).
10. Vacuole (storage, transportation). 11. Cytosol (liquid found inside cells which acts
as a site for multiple cell processes). 12. Lysosome (digestion of large macromolecules).
13. Centrosome (cell division) 14. Membrane (separate extra- and intracellular envi-
ronment) [255]
3.2.5.1 MTT assay
The MTT assay is a colorimeric assay used to assess cell viability. This assay measures
the reduction of the yellow 3-(4,5-dimethythiazol-2yl)-2,5-diphenyl tetrazolium bromide
(MTT) by a mitochondrial enzyme succinate dehydrogenase. The MTT molecule is able
to enter the cell and passes into the mitochondria where it is reduced to an insoluble,
coloured (purple) formazan product (Figure 3.9). The cells are then solubilized with
an organic solved and the released and solubilized formazan reagent is measured spec-
trophotometrically. Since the reduction of MTT can only occur in metabolically active
cells, the level of cellular activity is a measure of the viability of the cells [256].
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Figure 3.9: Chemical structure of the MTT molecule before and after its reduction
inside the mitochondria.
3.2.5.2 Trypan blue assay
Analogous to the MTT, the trypan blue assay is a method to assess cell viability.
The trypan blue ( (3Z, 3’Z)-3,3’-[(3,3’-dimethylbiphenyl-4,4’-diyl)di(1Z)hydrazine-2-yl-
1-ylidene]bis(5-amino-4-oxo-3,4-dihydronaphthalene-2,7-disulfonic acid) ) is a blue dye
and it can color dead tissues or dead cells. However, its action is not based on the
mitochondria, but on its ability to cross (or not) the cellular membrane. The cellular
membrane is selective permeable. This directly means that the membrane acts as a
barrier protecting the cell and controlling what can be internalized. In viable cells, the
trypan blue molecule is not absorbed, however when the cell is not viable (dead), this
molecule can cross the membrane and hence dye it intracellular environment with a blue
color (Figure 3.10) [257]. Hence it is possible to count the number of dead cells, by
excluding the live cells. Therefore this method is also described as the dye exclusion
method.
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Figure 3.10: Figure showing the trypan blue chemical structure. When the trypan
blue molecule is in contact with live cells, it cannot penetrate the membrane and there-
fore the cells can be seen in an optical microscope When the trypan blue molecule
penetrates the cell membrane, its intracellular environment get stained in blue and
indicates that the cell is dead (not viable).

Chapter 4
Synthesis of carbon-based
nanoparticles
The fourth chapter of this work is dedicated to describing the synthesis routes of the
nanoparticles investigated in this work. Initially the synthesis of iron oxide nanoparticles
is presented, followed by the synthesis of nanographene oxide nanoparticles and the last
section of this chapter presents the synthesis of graphene nanoshells
4.1 Synthesis of monodispersed iron oxide nanoparticles
coated with graphene
Magnetic nanoparticles are of great interest for use in a wide range of disciplines and are
expected to play an ever more important role in biotechnology and biomedicine. Novel
methods in treatment and diagnostics are being developed using nanoparticles (NPs)
with the promise of overcoming many of the limitations of current procedures. Nonethe-
less, dextran coated iron oxide nano-particles are the only form of NPs thus far approved
by the US Food and Drug Administration (FDA). The interest in iron oxide NPs lies
in their potential as elements for contrast enhancement in magnetic resonance imaging,
tissue repair, immunoassay, detoxification of biological fluids, cell separation, drug de-
livery and hyperthermia [258–264]. The scientific curiosity with regards to nanoparticles
stems from their size dependant-properties that mainly originate from the dominance
of their large surface area. Moreover, the morphology of NPs can be an intrinsic func-
tionalization in itself [265]. However, the impact of the size and shape of NPs on their
toxicological effects is only beginning to be investigated and its understanding is crucial
for designing their physical and chemical properties more accurately and according to
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the requirements for a given application. Stoher et al. [266] found spherical silver nano-
and microparticles exhibit little impact on alveolar epithelial cells whereas wire-shaped
silver particles induced a strong cytotoxicity, loss in cell viability, and early calcium in-
flux. Another recent study with silica NPs showed that variations in their shape and size
can trigger different cellular responses and even influence the cell migration on surfaces
[267]. Various other studies hint that NPs size and shape can trigger different cellular re-
sponses in endocytic pathways, cell viability and early apoptosis [268–271]. Theoretical
and experimental studies with iron oxide NPs with large diameter distributions suggest
that particles of different diameters could be internalized differently by cells which could
lead to different biological responses. However, the mechanisms involved are still unclear
[272]. Ying and co-workers investigated the cytotoxicity of iron oxide NPs with different
sizes and coatings on A3 human T lymphocytes using commercial NPs for which no in-
formation on their diameter distributions was available [273]. Another study compared
various metal oxide particles including iron oxide, again using only a single cell line. The
diameter distributions of the investigated NPs were very large [274]. Ideally studies with
very narrow diameter distributions, so called monodisperse samples, are thought to be
preferable so as to avoid any size dependency that may or may not exist within the ob-
served diameter distribution. To our knowledge no systematic study on size dependency
of cytotoxicity using iron oxide NPs with highly defined diameter distributions across
multiple cell lines exists so far. Even though iron oxide NPs are regarded as stable [275],
there is the risk that NPs in general can react when in direct contact with an external
biological environment. This can lead to their degradation resulting in toxic byproducts
[276]. A promising means to overcome this problem is to use coatings that can also
provide these particles with new and enhanced properties [277]. Some examples include
polymers [278, 279], surfactants [280]. Even differences in the surface charge of NPs can
be recognized by cells [281]. Carbon coatings are attractive because they do not only
offer high chemical and thermal stability, but also provide a platform that can be easily
functionalized [282–285]. In the case of magnetic NPs (e.g. iron oxide), carbon coatings
can also help to reduce magnetic interparticle interactions and thereby hinder agglomer-
ation [286]. Indeed carbon-based nanostructures are potentially attractive for a variety
of applications in biomedicine ranging from drug delivery to biosensing [287–291]. There
is an increasing number of publications relating the cytotoxicity levels of nanoparticles
to their morphology with special emphasis on size, shape, and surface defects. How-
ever this correlation between morphology and cytotoxicity has been mostly investigated
for nanoparticles pursuing extreme differences such as comparing 10 nm particles with
100 nm ones or using samples that do not have a homogeneous nature (e.g. difference
shapes and sizes intermixed within a sample). Here we deliberately focus on a small
range of diameters and narrow specific diameter distributions of purely spherical iron
oxide nanoparticles. To our knowledge there is still a need to determine if cells are
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able to discriminate between small diameter variations in the order of 10 nm, namely
when differences in the size of NPs start to be significant and measurable when brought
together with cells. In this work we aim to investigate a small range of diameters of
iron oxide NPs. For this we use a colloidal chemistry route involving the decomposition
of iron oleate to synthesize spherical iron oxide NPs [292]. Moreover, the technique
inherently leaves a thin carbon rich coating on the surface of the as-produced NPs. The
implemented synthesis route is attractive because, apart from yielding NPs with highly
defined diameter distributions, it is also possible to tailor the mean diameters of the
NPs by varying the reaction conditions. We also show that one can tailor the width
of the diameter distribution by altering the purity of the precursors. This allowed us
to produce three very narrow size distributions (9.7, 14.8 and 16.8 nm) and full width
at half maximum (FWHM) corresponding to 1.4 nm, 1.4 nm, 2.5 nm, respectively. In
addition, a fourth sample with a broad diameter distribution (20.3 nm) and FWHM of
5.5 nm spanning the diameters of the initial three samples was prepared. These samples
enable us to investigate two important questions, which will be addressed in chapter 5.
Firstly, are the cytotoxicity and cellular uptake influenced by small diameter changes
and secondly, are the cytotoxicity and uptake sensitive to broad diameter distributions
as compared to narrow diameter distributions? This latter question is important when
considering the synthesis of high performance NPs on an industrial scale where a broad
diameter distribution usually implies reduced production costs. The as-produced sam-
ples were carefully characterized and their biocompatibility was evaluated. In order to
determine the material toxicity and the possible size dependence, four cell lines were
incubated with the NPs and the cell viability was measured using the MTT and trypan
blue assays. The standard cell lines used in the viability assays were HeLa Kyoto, human
osteosarcoma (U2OS), mouse fibroblasts (NIH 3T3) and mouse macrophages (J7442).
The characterization and biological evaluation are shown in Chapter 5.
4.1.1 Experimental
The iron oxide NPs were synthesized based on the work of L. M. Bronstein [293], which
is now briefly explained. A typical procedure to synthesize iron oxide NPs with highly
defined sizes is based on the iron oleate complex serving as a precursor. This complex
is formed in the reaction between iron chloride (III) and sodium oleate dissolved in
a mixture of ethanol, hexane and distilled water. When heated for 4 hours on a hot
plate, the metal chloride and the sodium oleate react to form a metal-oleate complex
(iron oleate) and sodium chloride (NaCl). The resulting mixture containing the iron
oleate is then washed with distilled water to remove the salt byproduct and the oleate
is isolated using a separation funnel. The purified and waxy complex is then thermally
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decomposed by boiling in a high temperature solvent. Following a modified procedure
of the original synthesis route [293], the iron oleate complex passes through a two-step
process, which allows the formation of NPs with different diameters. As a first step the
iron oleate complex is thermally treated in vacuum for 24 hours at 30 and subsequently
70 ◦C. This heating treatment removes crystal hydrate water and at 70 ◦C dissociates the
metal carboxylate bonds [293]. The second step is the thermal decomposition of the iron
oleate complex in different solvents. The use of various solvents to decompose the iron
oleate complex is important because each solvent has a different boiling temperature
at which the decomposition occurs and plays a role in the final monodispersed size
of the NPs. In other words the different temperatures influence the nucleation and
growth processes of the NPs. The different thermally treated iron-oleate complexes were
firstly dissolved in a mixture of oleic acid and different solvents (octadecane, octadecene,
eicosane and docosane) and heated up for different periods of time and temperature in
a reflux system. The solution, which then contains the iron oxide crystals, is afterwards
cooled down to room temperature. Ethanol and acetone were used to precipitate the
crystals, which were collected using a strong magnet. Moreover all samples were intensely
rinsed with organic solvents (chloroform and hexane) and again collected using a strong
magnet. This process was used to remove possible remnants from the oleic acid, avoiding
in this way an unwanted coating oleic acid on the NPs. It is important to mention
that the iron oleate complex used in the synthesis of the sample containing the NPs
with an average diameter of 20.3 nm was not annealed in vacuum and used precursor
chemicals with different impurity contents, which led to the formation of a broad size
distribution. A small amount of the dried samples are shown in Figure A1 of Appendix
A The commercial chemicals FeCl3.6H2O (98 %), docosane (99 %), eicosane (99 %),
octadecane (99 %) and octadecene (99 %) were purchased from Alfa Aesar. Hexane,
ethanol, chloroform, acetone and oleic acid were purchased from Merck Chemicals. The
sample containing the iron oxide nanoparticles with the broad size distribution (Sample
D) was synthesized using the soldium oleate purchased from Sigma Aldrich with a purity
of 82 %, whereas the other samples with narrow distributions were synthesized with a
sodium oleate purchased from J. T. Baker with a higher purity (90-100 %).
4.1.2 Results
The morphology of the as-synthesized iron oxide NPs was studied using low voltage Cs
corrected transmission electron microscopy (LVTEM) at 80 kV. In Figure 4.1 ordered
arrays of iron oxide NPs formed on carbon membrane TEM grids are shown. The images,
as well as in-depth statistical analysis of the particles, reveal that the NPs presented in
Figure 4.1 panels A, B and C have highly narrow diameter distributions and all consist
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of spherical particles, whereas the NPs in Figure 4.1 panel D have a variation in size and
shape. The broader distribution varies from 10 – 26 nm and envelopes the sum of the
3 narrow diameter distribution samples. Both spherical and cubic NPs can be observed
in the samples shown in panel D of Figure 4.1. A statistical analysis was conducted for
at least 100 particles with each particle diameter measured at four positions and then
averaged.
Figure 4.1: TEM images showing the four as-produced samples. Panels A, B and
C show the NPs that have narrow diameter distributions while panel D has a broad
diameter distribution that envelopes the sum of A, B and C.
The as-produced material was analyzed using a transmission electron microscope (TEM
model JEOL 2010F), X-ray diffraction apparatus (Rigaku Miniflex), a Raman spectrom-
eter (Thermo Scientific DXR) and a Fourier transform infrared spectrometer (Bruker).
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4.2 Synthesis of nanographene oxide nanoparticles
The two dimensional sp2 hybridized carbon structure graphene presents extraordinary
properties in the field of material science and physics. It has attracted interest because
of its mechanical, optical and electronic properties. As covered in chapter 2, graphene
is also thought to have biological application. However, the latter is more promising
with an oxidized form of graphene (graphene oxide). The graphene oxide provides a
better platform to biological purposes because it is hydrophilic and therefore easy to
be dispersed in a physiological environment. These functional groups together with the
high loading capacity provide a unique way for further functionalization with drugs,
polymers and other biomolecules Here it will be shown how an easy and relatively fast
approach to synthesize different sizes of graphene oxide flakes. The characterization of
the material is also conducted and later on chapter 5 it is presented how this material
interacts with biological cells.
4.2.1 Experimental
The nanographene oxide (NGO) was produced from the commercially available natural
graphite and was based on a modified Hummers method [126, 129]. The summarized
process to produce the different sizes of NGO are now briefly described. Firstly, 1 g of
the commercially available graphite was ground with 50 g of Sodium chloride (NaCl)
for 15 min in order to t te exfoliation process of graphite as well as reduce its size. In
order to remove the NaCl, the grounded graphite mixed with NaCl was then dissolved
in distilled water at the temperature of ca. 55 ◦C and filtrated using a 450 nm porous
TEFLON filter paper by suction filtration. The filtrated graphite was mixed in 23 ml
95 % sulfuric acid (H2SO4) and left it stirring vigorously for overnight. Afterwards, the
temperature of the mixture was kept constant at 10 ◦C in an ice bath and 3 g potassium
permanganate (KMnO4) was added gradually over 3 h with constant stirring. After the
addition of KMnO4 was completed, the mixture was sonicated for 3 h and continuously
stirred for 30 min at 35 ◦C and 45 min at 50 ◦C. Finally, 46 ml distilled water was added
to the mixture and kept stirring at 100 ◦C for 45 min. The mixture was cooled down
to room temperature and stirred with the addition of 140 ml distilled water and 10 ml
of 30 % hydrogen peroxide (H2O2). The final solution filtrated and washed 10 times
with 5 % HCl and distilled water to remove any reaction byproducts and the oxidized
graphene was collected. In order to further reduce both the width (lateral cracking) and
thickness (exfoliation) of the oxidized graphene flakes, it was mixed with distilled water
and using a horn-tipped ultrasonic probe, the solution was sonicated for different time.
In this work two different sizes of NGO was produced. The one containing flakes with
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an average size of 277 nm and 4 layers (ca. 1.4 nm) was tip-sonicated for 30 min and
another one containing flakes with an average size of 89 nm and 6 layers (ca. 2.1 nm)
was tip-sonicated for 4 hours.
4.2.2 Results
The morphology of the two as-produced nanographene oxide NPs samples was stud-
ied using various techniques. In Figure 4.2 from panel A to C it is possible to see a
SEM, an AFM and a TEM images of the nanographene sample containing flakes with
277 nm in diameter and approximately 4 graphene layers. In Figure 4.2 from panel
D to F it is possible to see a SEM, an AFM and a TEM images of the nanographene
sample containing flakes with 89 nm in diameter and approximately 6 graphene lay-
ers. Statistical analysis was conducted for at least 100 particles with each particle’s
diameter measured at four positions and then averaged. The solution containing the
nanographene samples in aqueous solution is shown in Figure A2 in Appendix A.
Figure 4.2: Panel A shows the SEM image of NGO with 277 nm in diameter, while
panel B shows an AFM image where the measured height of NGO was 4 layers. Panels
D to F show the same set of measurements for a second sample containing NGO particle
with 89 nm and 6 graphene layers.
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4.3 Synthesis of graphene nanoshells
A single layer of carbon atoms with sp2 hybridization arranged in a honeycomb lattice
known as graphene shows exceptional structural [294], physical [295] and chemical prop-
erties [296] and has captured the imagination and attention of many research groups.
Graphene and its few-layer counterparts show amazing potential in numerous appli-
cations and is driving cutting edge research in areas related to energy storage [297],
electronic devices [298], biomedical applications [299] and material science [300]. When
mechanically isolated graphene from highly ordered pyrolitic graphite was first reported
[301], the research world turned to finding new and cheap methods to obtain graphene
with comparable structural quality, viz. a near perfect carbon atom arrangement in a
honeycomb lattice with analogous properties. This has led to an explosion in routes
for synthetic graphene. The primary routes include the chemical exfoliation of graphite
[302], thermal sublimation of epitaxial silicon carbide [303] and chemical vapour de-
position (CVD) of hydrocarbons (over single crystals,[304] metal foils [305], thin films
[306], nanoparticles [307]). Of these fabrication routes, CVD shows the most promise
due to its easy scale up potential, ease of use and that it is already a well-established
technique in many industrial applications. Moreover, fabrication of graphene can be
accomplished over nanoparticles making it a simple and attractive means for the prepa-
ration of three-dimensional (3D) nano-structured graphene [308]. 3D nano-structured
graphene holds promise in applications such as sensors [309], supercapacitors [310] and
catalytic electrodes [311]. In addition, 3D graphene nanostructures, like other sp2 car-
bon nanomaterials, are easily surface-functionalized. They may also be filled (in their
core). In other words, they can carry payloads, for example, with magnetic metals or
drugs for biomedical applications. Thus, 3D graphene nanostructures show potential in
a variety of applications. The easiest way to form 3D graphene nanostructures is by
their synthesis over specific nanoparticles, viz., templated growth. There are three main
types of the nanoparticles which can be used as templates, namely: metals [308], oxides
[312–314] and carbides [315]. Metals and oxides based structures have big advantage
over carbide based structures in that they can easily be removed from the core using
straight forward wet chemical approaches (e.g. dissolving in acids), whereas carbides are
highly challenging to eliminate. The use of metal nanoparticles, as for example, nickel,
provides a relatively cheap way to fabricate graphene coated core shell nanostructures
through a carburization process. In general, the metal cores are also easily eliminated
through post synthesis treatment e.g. hydrochloric acid removal [308]. However, in case
of metal nanoparticles removal there is always the risk of metal remnants after the purifi-
cation process making the 3D graphene nanostructures potentially toxic. In this regard,
oxide nanoparticles serving as the template surface are more attractive than metallic
nanoparticles for the preparation of 3D graphene since for the most part they are far
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less toxic. Moreover, their morphology means they are not susceptible to pathogenic
effects in the mesothelium due to frustrated phagocytosis as do 1D fibres (e.g. carbon
nanotubes, asbestos etc.) [316, 317]. Here we present a cheap and scalable fabrication
route for three-dimensional (3D) nanostructured graphene over oxide nanopowders via
a simple ethanol feedstock thermal CVD approach. We thoroughly characterize the as-
produced and processed synthetic material as well as examine their potential for further
functionalization, electrochemical application and test their toxicity. To process the ma-
terial we remove the core by simple dissolution in diluted acid to yield pure 3D hollow
graphene nanostructures.
4.3.1 Experimental
In order to synthesize the empty graphene nanoshells it is necessary a nanoparticle, which
will serve as a mold for the graphene formation. Hence, initially a few grams of an oxide
nanopowder, in this case magnesium oxide (MgO), was used as the template material was
placed in a ceramic crucible which was then positioned at the center of a horizontal tube
furnace. An argon flow (200 ml/min) was established and maintained while the furnace
was heated to a temperature of 775 ◦C. After the desired temperature, a second valve was
opened to inject an additional flow of Argon (Ar) saturated with ethanol (by bubbling Ar
gas (600 ml/min) through liquid ethanol). The reaction was maintained for 1 hour and
then the Argon/ethanol flow mix was shut off while maintaining a pure Ar (200 ml/min)
flow while cooling down naturally to room temperature. During this process graphitic
layers form over the oxide nanoparticles surface [315]. After cooling to room temperature
the product was removed and subjected to a variety of characterizations. The MgO
nanoparticles coated with graphitic layers was subjected to treatment in diluted HCl
(5 molar) to dissolve away the MgO core so as to leave hollow graphitic shells. After
treatment in HCl the material was thoroughly rinsed in deionized H2O. This process of
HCl treatment followed by thorough rinsing was conducted several times after which the
material was dried naturally.
4.3.2 Results
Application of the CVD route in which the oxide nanopowders (MgO) was exposed to
ethanol vapor at a temperature of 775 ◦C for a nominal time leads to the initially white
powder turning black (see Figure A3 in the Appendix A). Detailed TEM investigations
show a layered material on the surface of the nanoparticles with an inter-layer spacing
between 0.3 and 0.4 nm which is typical for few layer graphene coatings (Figure 4.3).
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Figure 4.3: TEM images of graphene-coated MgO nanoparticles is shown is A and
graphene nanoshells after magnesia removal shown in B.
Systematic TEM evaluations enable one to extract some statistics on the mean particle
size and range as well as the average number of graphene layers. These are provided in
Table 4.1 for the MgO coated with graphene and the graphene nanoshells.
Table 4.1: Details of the graphene coated oxide nanoparticles and carbon shells ex-
plored in the study.
Parameter C@MgO Graphene nanoshell
Mean diameter [nm] 40 (±1) 40 (±1)
Size range [nm] 15 - 80 15 - 80
Average number of layers 7 7
Nanoparticles/µg 9x109 4x1010
4.4 Summary
In this chapter it is shown that it is possible to synthesize iron-oxide nanoparticles with
very defined size distributions using a colloidal chemistry route. This technique provides
a way to produce large amount of material in a relatively low costs. This technique also
rendered nanoparticles with a thin layer of graphitic material. This graphitic material
might have been formed during the synthesis process and formation of the iron nanopar-
ticles, most probably due to the high temperatures used in the decomposition of iron
oleate. In this chapter we demonstrated that it is possible to synthesize different sizes
of nanographene oxide flakes using a modified Hummers method. By sonicating the
oxidized graphite for different periods, it was possible to reduce the size of the fakes and
therefore end up with two different sizes without overlapping the distributions. This
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technique yielded good quality material and can be scaled up. Finally in the last section
of the chapter we demonstrated that oxide nanopowders are attractive candidates for
encapsulation with few-layer graphene. The production of these graphene-coated ma-
terials is facile, inexpensive and can also be scaled up. Moreover, we showed that the
oxide core can be used as a template to the fabrication of pure 3 dimensional carbon
structures after the removal of the metallic core and leave the few-layer graphene shells
intact.

Chapter 5
Characterization and biological
evaluation of iron oxide
nanoparticles coated with
graphene
The carbon-coated iron oxide nanoparticles were synthesized and presented in section
4.1. The iron oxide nanoparticles samples were fully characterized prior to their bio-
logical evaluation. This chapter is divided into two different parts: (1) characterization
results and (2) the biological evaluation.
5.1 Sample characterization
5.1.1 Experimental
The morphological characterization (shape, diameter and coating) of the samples was
conducted using a TEM. The samples were dispersed in a non-polar solvent and a
5 µl droplet at a concentration of approximately 1 mg/ml was placed and dried on a
carbon film coated TEM grid. The crystalline structure of the samples were analysed
using an X-Ray diffractometer (XRD). The XRD pattern was used to estimate the
average crystal size and the results were compared with the TEM observations. The
presence of sp2-carbon was studied using Raman spectroscopy (laser λ = 532 nm).
To examine the different NPs samples they were pressed and fixed on Si/SiO2 wafers
prior to the measurement. The as-produced samples were dried and small amounts
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of the powder were weighed before both the magnetization over external field (MxB)
and temperature (MxT) were conducted in a VSM-SQUID from Quantum Design. The
heating experiments were performed in a purpose built equipment with an operating
frequency of 120 Hz. The samples were dispersed in an aqueous solution using a tip
sonicator with a concentration of 5 mg/ml and measured over 4 minutes.
5.1.2 Results
High resolution LVTEM investigations show that the iron oxide NPs are single crystals
and have a graphitic coating. Panels A-D of Figure 5.1 show typical examples of crys-
talline iron oxide NPs for the NPs with 9.7, 14.8, 16.8 and 20.3 nm, respectively. The
surface of the NPs has a layered structure (see arrows) hinting at a graphitic coating.
Typically the coating thickness is 0.5 – 1.0 nm, which corresponds to 1 – 3 graphitic lay-
ers. To investigate the coating in more detail we employed Raman spectroscopy. This
technique is sensitive to sp2 carbon materials, in particular to the presence of the so
called G mode (ca. 1600 cm−1), which appears due to bond stretching of all sp2 carbon
pairs in both rings and chains, and the D mode (ca. 1350 cm−1), which is due to the fact
that breathing modes of sp2 atoms in rings can provide signatures for the presence of
graphitic material [318]. Figure 5.1 F shows a typical Raman spectrum in which both the
G and D modes are present. The modes are broad and the D mode, which is activated by
defects, is rather large. These factors indicate a rather defective graphitic material. The
carbon coating probably consists of defective turbostratic graphene-like layers. Despite
the exact mechanisms involved in the formation of this thin graphene-like layers are not
investigated in more detail, They are likely formed during the decomposition process due
to the high temperatures used. The energy dispersive X-ray spectroscopic (EDS) studies
show only the presence of carbon (C), oxygen (O) and iron (Fe) indicating that the as-
produced iron oxide NPs coated with carbon are pure. Additionally, Fourier transform
infra-red (FTIR) studies were conducted to better investigate the NP surface coating
and the spectra is shown in Figure 5.1 G. The FTIR data show a variety of functional
groups, namely, a C-O bond with a peak at 805 cm−1, a bending mode peak of C-C
can be seen at 1050 cm−1, a C=O bond with a peak close to 1700 cm−1 and C-H and
O-H bonds are present at higher wavenumber values above 2500 cm−1. The strong peak
appearing at 550 cm−1 is assigned to ferrite. The presence of these groups contributes to
the dispersion of the NPs in aqueous solution after ultrasonication. However it cannot
be excluded that traces of oleic acid may also be present. The existence of oleic acid
has been observed in other samples produced from this synthesis route, however, this
molecule is not toxic and can itself form a platform for further functionalization [319].
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Figure 5.1: TEM images with arrows highlighting the graphitic coating are shown in
(A) to (D). In (F) the Raman spectra show the presence of D and G modes confirming
the presence of sp2 carbon. In (G) the infrared spectroscopy indicates the presence of
functional groups.
The crystalline structure of the samples was studied using X-ray diffraction (XRD).
Typical XRD patterns are provided in Figure 5.2 A. From the XRD data the average
crystal size can be estimated according to the Scherrer equation [320].
Dhkl =
K.λ
β.cos(θ)
(5.1)
where K is a shape constant factor (for spherical NPs K=0.9), λ is the X-ray wavelength
(1.546 Å), β is the full width at half maximum (FWHM) expressed in units of 2θ
(radians) and θ is the Bragg angle (in radians). The average crystal diameter (Dhkl) for
each sample was calculated and is shown in Table 5.1. The values are in good agreement
with the average particle size determined in the LVTEM investigations.
Analysis of the lattice spacing values does not provide sufficient information to differ-
entiate between the magnetite (Fe3O4) and maghemite (γ-Fe2O3) phases since their
signature peak positions are very similar. The use of Mößbauer spectroscopy can dif-
ferentiate between the NPs phases. It is however important to mention that the NPs
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Table 5.1: Main parameters used to synthesized different size iron oxide nanoparticles
and comparison between LVTEM mean diameter evaluations and diameter estimates
using the Scherrer equation.
Sample Anneal
vac.
[◦C]
Solvent Reflux
temp.
[◦C]
Reflux time
[min]
TEM diam-
eter [nm]
Scherrer
size [nm]
A 30 Octadecane 318 30 9.7 (±1.4) 12.3 (±4.5)
B 70 Docosane 365 3 14.8 (±0.8) 14.3 (±4.8)
C 70 Eicosane 335 30 16.8 (±1.4) 16.7 (±5.3)
D - Octadecene 300 30 20.3 (±2.6) 18.3 (±9.2)
used are carbon-coated so that in terms of surface interaction with the environment the
phase of the nanoparticle is of minor relevance. Nonetheless the NP phase was indi-
rectly probed using a simple method described by Sun and Zeng [321] to differentiate
between the magnetite and maghemite phases. The technique relies upon the fact than
when annealing in air magnetite converts to the hematite (α-Fe2O3) phase whereas the
maghemite phase does not change. Since the XRD pattern of hematite is very distinct
from the other iron oxide phases the annealing process helps to identify the presence
of magnetite. The result of the annealing process is shown in Figure 5.2. The XRD
reflexes clearly show that the diffraction patterns of samples with diameters of 9.7 and
14.8 nm have new peaks characteristic of the hematite phase at the crystalline coordi-
nates (104), (113), (024), (116), (300), while the XRD reflexes of the samples with 16.8
and 20.3 nm remain unaltered. The data suggests that these two samples with smaller
mean diameters are mostly composed of magnetite, while the two samples with larger
mean diameters comprise the maghemite phase. This finding follows an opposing trend
to that found by Park et al. [292], who observed an increase in magnetite content with
increasing particle size. We attribute this difference to slight variations in some of our
synthesis parameters such as the synthesis atmosphere and temperature (e.g. we did not
use a rotary heating system).
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Figure 5.2: XRD reflexes before and after annealing in air are shown in (A) and (B),
repectively.
We also conducted magnetization studies (Figure 5.3). The hysteresis curves confirm
that the NPs pursue a ferromagnetic nature, whilst the exact stochiometry of the sam-
ples could not be calculated from the magnetization curves since the difference in the
magnetization saturation (MS) suggest either a mix of phases and/or presence of non-
magnetic material, for example diamagnetic organic material concomitant with a carbon
coating.
Figure 5.3: Hysteresis curves for all NP samples performed at 300 K. The inset shows
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In order to further study the magnetic properties, the field-cooled (FC) and zero field-
cooled (ZFC) curves (MxT) were measured and are shown in Figure 5.4.
Figure 5.4: Panels A to D show the FC and ZFC magnetizations of samples contain-
ining NPs with 9.7, 14.8, 16.8 and 20.3 nm, respectively.
The TEM data analysis of the NPs showed that they are nearly monodisperse distri-
bution, except the sample containing NPs with 20.3 nm. The magnetic data, on the
other hand, suggest that the samples have rather large size distributions, which is as-
signed as a result of interparticle interactions, due to agglomeration of the nanoparticles.
Therefore, it is expected that the magnetic data show a large distribution of blocking
temperatures. If we consider an ideal system containing non-interacting magnetic NPs,
it is possible to use the derivative of the difference between the FC and the ZFC mag-
netization modes (MFC-MZFC) with respect to the temperature (T). This derivative
represents the distribution of blocking temperatures[322]. Figure 5.5 shows the deriva-
tive –d(MFC-MZFC)/dT. Using the mean value of the blocking temperature distribution
it is possible to estimate the mean particle size with the equation [323]
TB =
K.V
25.kB
(5.2)
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where TB is the blocking temperature, K is the anisotropy constant, V is the particle
volume and kB is the Boltzmann constant.
In Figure 5.5 one can notice that all samples have a broad distribution of blocking tem-
peratures. The sample containing the 9.7 nm NPs (Panel A) have a single blocking
temperature peak, but a rather broad distribution. For each sample the blocking tem-
perature can be extracted and assigned to the main broad peak. Each average blocking
temperature matches well with the size measured using TEM and the broadness and
asymmetry of the peaks can only be related to the agglomeration of the nanoparticles.
Figure 5.5: Panels A-D show the derivative of the difference between FC and ZFC
magnetizations in respect to temperature for all samples.
5.2 Cytotoxicity and uptake studies of iron oxide nanopar-
ticles coated with graphene
Here it is going to be presented the toxicity tests performed using the biological assays.
To test the metabolism of the cells the MTT assay was used, whereas to directly count
the number of dead cells the trypan blue assay was used. The internalization studies were
performed using a TEM after the samples were accordingly prepared for this purpose.
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Table 5.2: Estimation of particle size using blocking temperature distribution
Sample TB [K] Particle size [nm]
(Kmagnetite=1.35x10
4J.m−3)*
Particle size [nm]
(Kmaghemite=4.60x10
3J.m−3)**
Particle size [nm]
(Kaverage=9.05x10
3J.m−3)
A 39 12.4 17.6 14.1
B 10 7.8 11.2 9.0
121.7 18.1 25.9 20.7
C 16.5 9.3 13.3 10.6
134 19.0 26.7 21.3
D 14.8 8.9 6.42 10.2
38.5 12.3 8.83 14.1
105.5 17.2 12.3 19.7
194 21.2 30.2 24.2
* see reference [324, 325]
** see reference [326]
5.2.1 Experimental
Cell culture: HeLa cells (Kyoto line) were cultured in DMEM+GlutaMAXTM (gibco)
supplemented with 1 % NEAA (gibco); human osteosarcoma U2OS cells (GFP-53BP1)
in standard DMEM (Sigma-Aldrich) supplemented with 1 mM pyruvate and 0.5 mg/mL
genectin (gibco) and NIH 3T3 mouse fibroblast as well as macrophage J7442 cells were
grown in DMEM F12HAM supplemented with 2 mM l-glutamine (Sigma-Aldrich). Ad-
ditionally all the media contained 10 % FBS (Sigma-Aldrich), 100 U/mL penicillin and
100 µg/mL streptomycin (gibco). To create a cell suspension the cells were washed
once with PBS (gibco) and detached using a cell scraper for the macrophages (Greiner
Bio-One) or for the other cell lines, 0.25 % Trypsin-EDTA solution (Sigma).
MTT viability assay : For cell viability studies, a commercial TOX-1 in vitro toxicology
assay kit (Sigma-Aldrich) was used. The assay measures the viability of living cells via
the cleavage of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) to
purple formazan crystals by the cells’ mitochondrial dehydrogenases. Four different cell
lines were grown in standard 96 well flat-bottom plates as testing systems and 4.0x105
cells per well were tested. The NPs were suspended in DI water at a stock concentration
of 0.5 mg/mL. To assure a uniform dispersion of the particles the suspensions were
vortexed (stirred) on a Vortex Genie 2T for 2 min prior to usage. After incubating the
cells at 37 ◦C and 5 % CO2 in the presence of increasing concentrations of NPs (controls
with only DI water, 1 µg/mL, 10 µg/mL and 100 µg/mL) for either 12 or 48 h, 10 µL of
the MTT solution (5 mg/mL in PBS) was added to the 0.1 mL culture medium per well
and the 96 well plates were returned to the incubator for another 4 h. After carefully
removing 80 µL of the supernatant the produced formazan crystals were then dissolved
in 0.1 mL of the prewarmed MTT Solubilization Solution (10 % Triton X-100, 0.1 M
HCl in anhydrous isopropanol) by gently shaking the plates in an ELISA microplate
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reader (15 min, 14 Hz, 37 ◦C, SAFAS MP96). The absorbance of the formazan dye
was measured in the SAFASMP96 reader at 550 nm/650 nm within an hour and after
having substracted the background from the sample, the percentage cell viability was
calculated. Each of the conducted experiments was repeated three times.
Dye exclusion test (Trypan Blue): The cell lines were grown in standard 6 well flat-
bottom plates and incubated for 12 or 48 h with the respective nanoparticle suspension
at a concentration of 10 µg/mL. Afterwards the cells were detached and resuspended
in 1 mL cell culture Medium per well. 20 µL of each cell suspension were carefully
mixed with 0.4% trypan blue solution (Sigma) and added to the chambers of a standard
hemocytometer (improved Neubauer) to count the number of viable and dead cells. The
results are presented as means of two measurements each and their deviation.
Live cell imaging : Cells were cultured in 6 well plates. Images were acquired with an
Axio Observer Z1 inverse microscope equipped with a 37 ◦C heated stage and CO2
chamber. The software Axio Vision Rel. 4.8 (Carl Zeiss, Inc.) was used for the image
acquisition.
TEM investigations: The cells were grown as a monolayer in a humidified incubator in
the conditions described above. The cells were seeded in a 6 cm petri dish for 4 h prior
to the incubation with the NPs. After this adhesion period the bottom the cells were
treated with the NPs in a concentration of 10 µg/ml for a period of 48 h. The cells
were collected from the culture dish and centrifuged at 1000 rpm for 5 min, and the
supernatant was removed. The cell pellets were fixed in a 2.5% gluteraldehyde for 4 h.
They were then rinsed with PBS, embedded in 4% agarose gel, a second fixation step
was conducted in 2% osmium tetroxide solution for 24 h and then rinsed with distilled
water. The samples were stained with 1% uranyl acetate for 1.5 h, dehydrated in a
graded series of acetone (25, 50, 75, 96 and 100%), and embedded in epoxy resin. The
resin was polymerized firstly for 3 h at 50 ◦C and then the temperature increase to
60 ◦C for 48 h. Ultrathin sections (50–70 nm) obtained with a ultramicrotome and
imaged using transmission electron microscope (TEM) JEOL 2010F retrofitted with
two third order Cs aberration correctors operating at 80 kV and a FEI TECNAI T20
operating at 200 kV.
5.2.2 Cytotoxicity evaluation
The size dependent cytotoxicity of the carbon-coated iron oxide NPs was investigated.
Four different cell lines (HeLa Kyoto, human osteosarcoma U2OS, fibroblasts (NIH 3T3)
and macrophages (J7442)) were incubated with the NPs dispersed in water at three
distinct concentrations (1, 10 and 100 µg/ml) for a period of 12 and 48 h. In order
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to quantify the toxicity of the different NPs two different approaches were used. First,
the number of viable cells was measured with a colorimetric assay that is based on the
reduction of yellow MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide)
to purple formazan crystals by mitochondrial dehydrogenase enzymes. The cleavage of
MTT occurs only in living cells so that the amount of the produced formazan crystals is
proportional to the number of living cells. In addition, to exclude the possible influence
of the NPs on the test results, cell-free tests were simultaneously conducted. The MTT
assay does not provide any information as to whether the NPs themselves cause cell death
or whether they simply reduce the cellular metabolic activity. Hence we implement a
second approach, the dye exclusion method with trypan blue. The cell viability assay is
based on the exclusion of the blue dye from healthy cells. In dead cells the membrane
is no longer functional (ruptured) and the dye is able to cross the membrane, staining
the cell interior. Using a visible light microscope, the dead cells are observed to be dark
blue instead of bright. Incubation for 12 hours with cells: The MTT assay was first
performed for an incubation period of 12 hours. The data from the MTT assay of this
short-exposure are provided in Figure B1 in Appendix B. The results suggest it is not
possible to relate the decrease in viability between the cells lines tested to the size of
the NPs. The trypan blue test conducted for the short-exposure time (12 hours) also
demonstrates no change in viability as can be seen in Figure B2 in the Appendix B. As
with the MTT assay, no size dependence was observed in the trypan blue assay.
Incubation for 48 hours with cells: In order to observe any time-dependent influence
of toxicity, the MTT assay was measured for a long exposure time (48 hours). This
data shows slightly different values of cytotoxicity as compared to the short-exposure
time. The MTT viability results for each cell line are provided in Figure 5.6 (A-D).
For the four investigated cell lines the nanoparticle solutions with a concentration of 1
µg/ml did not show a toxic effect. For a NP concentration of 10 µg/ml there is a slight
decrease in viability, which is more pronounced for the macrophage cell line (in Figure
5.6D). With a NP concentration of 100 µg/ml all cell lines show an obvious decrease in
viability. Both the human HeLa (Figure 5.6A) and osteosarcoma (Figure 5.6 B) cells
lines show a higher resistance to the NPs as compared to the mouse cell lines. This
difference is most evident when comparing the NP solutions of 100 µg/ml. Despite
the decrease in viability when compared to the short-exposure incubation periods, the
data show no apparent size dependence or diameter distribution dependence on toxicity
within the explored diameter range. The results suggest that the toxicity of the NPs
is primarily defined by the nanoparticle concentration. The dye exclusion test (trypan
blue) was also conducted for the smallest and biggest NP diameters (9.7 and 20.3 nm).
In Figure 5.6E a typical light micrograph of the cells treated with the dye is shown. The
arrows indicate blue and therefore dead cells. The results for all cell lines and a NP
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concentration of 10 µg/ml are shown in Figure 5.6F. The HeLa, osteosarcoma (U2OS)
and fibrobrast (NIH 3T3) cell lines do not exhibit a prominent change in viability, while
the macrophages (J7442) do show a slight decrease in viability. This decrease is however
less than that observed in the MTT assay. This indicates that the cells incubated with
the carbon-coated iron oxide NPs tend to undergo a reduction in mitochondrial activity
(indicated by MTT assay) rather than die (as indicated by the trypan blue assay).
Figure 5.6: Percentage viability of different cell lines in dependence on the nanoparti-
cle diameter for three different nanoparticle concentrations using the MTT assay (green:
1 µg/mL, orange: 10 µg/mL, white: 100 µg/mL) for A) HeLa Kyoto, B) human os-
teosarcoma U2OS (GFP-53BP1), C) NIH 3T3 fibroblasts and D) Macrophages J7442.
Error bars represent the standard deviation; *: p ≤ 0.05 and **: p ≤ 0.001. In panel
E an example of a light micrograph image of the trypan blue viability assay is shown
(the arrow indicates a dead cell) and in panel F the comparison of the percentage cell
viability for the different cell lines for two nanoparticle diameters (green: untreated
cells, orange: 10 nm Nanoparticle and white: 20 nm Nanoparticle 48 h incubation) is
provided. The nanoparticle concentration in each case is 10 µg/mL.
Cluster formation: In practice, some NPs will agglomerate due to magnetic interac-
tions, and to a lesser degree through van der Waals interactions. Indeed visible light
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microscopy studies of the NPs confirm the presence of clusters in the NP solution. To
investigate if there is a dependence of the cluster size on toxicity the MTT and trypan
blue tests for the smallest and largest diameter samples (samples with 9.7 nm and with
20.3 nm) were repeated. For the new set of experiments, two cell lines were explored
(Hela Kyoto and macrophages) and the NP samples were sonicated in order to obtain
a better dispersion of the NPs in the aqueous solution. The HeLa Kyoto cell line was
chosen as a standard human cell line whose toxic response did not significantly differ
from the osteosarcoma one and as a mouse cell line, the macrophages were chosen be-
cause they showed the highest sensitivity. Before incubating the NPs with these cells,
the solutions were sonicated for 50 h to dissociate formed clusters. From visible light
microscopy investigations the mean cluster size for the NPs with 9.7 nm was reduced
by 70% and for the sample with NPs with 20.3 nm a 45% reduction was observed. It is
also important to note that the same experiments with the sonicated samples were also
conducted and in this case there was neither an increase nor a decrease in viabilitity (see
in Figure B1 and B2 in the Appendix B). The data for the MTT and trypan blue studies
are provided in Figure 5.7. The MTT assay shows an increase in mitochondrial activity
as compared to the non-sonicated samples initially investigated. This effect was more
prominent for the macrophages. The increase in viability for the sonicated samples was
more evident for the highest concentration of NPs used (100 µg/ml). These observations
are in accordance with the trypan blue assay (see Figure 5.7 D). This difference is most
probably assigned to the fact that the big clusters precipitate and accumulate on top
of the cells, forming a rather large amount of material that eventually influences the
cell proliferation. The samples with improved dispersion will have a larger number of
small clusters and individual NPs that either do not precipitate or can be internalized
and processed by cellular organelles. This leads to a relative increase in cellular activity
as we observe. Transmission electron microscopy studies, discussed below, confirm the
cells do uptake individual NPs and small clusters as opposed to large clusters. This
indicates that the carbon-coated iron oxide NPs are tolerated by cells even for large
concentrations when the NPs are well dispersed or with small clusters.
5.2.3 Uptake studies
The uptake of the carbon-coated iron oxide NPs was investigated using visible light mi-
croscopy and TEM. The visible light microscopy studies were conducted for all four cell
lines for the NP concentration of 10 µg/mL. Two representative snapshot images are
provided in Figure 5.8, panels A and B. The live observation of the cells incubated with
NPs shows that they are able to carry large clusters that seem to be attached to their
membrane. The cells however appear to continue their regular proliferation cycle (see
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Figure 5.7: Panels A and B show the MTT assay conducted with the HeLa and
macrophages for the sonicated nano-particles with the smallest (9.7 nm) and biggest
size (20.3 nm) diameter. The experiment was performed for different concentrations
(green: 1 µg/ml, orange: 10 µg/ml and white: 100 µg/ml). This assay with the
sonicated nano-particles shows an increase in cell viability in comparison to our initial
tests. Panel D shows an example of the cells treated with the trypan blue - the arrows
indicate dead cells. Panel D shows the results for the two cell lines treated with the
nanoparticles.
video frames in Figure B3 in the Appendix B). In addition, the macrophages tend to ac-
cumulate around the clusters, possibly in an attempt to conduct phagocytosis -a process
in the natural immune response to remove pathogens and cell debris. To determine if the
observed clusters were internalized, micrographs of different focal planes within the cells
were taken and analyzed. The z-stacking of the images are shown in Figure 5.8A and
B. Unfortunately, although the NPs/clusters were obviously in contact with the cellular
material, their internalization could not be fully resolved by this technique and thus the
study was inconclusive. Hence, studies with TEM were conducted. The TEM analysis
of the treated HeLa cells (Figure 5.8C) and macrophages (Figure 5.8D) shows that both
cell lines internalize rather large amounts of NPs. In Figure 5.8E a higher magnification
image of the internalized NPs are distinguishable. Both small clusters (less than 100
nm) and individual NPs can be seen inside the endosome. No large clusters were ever
observed within cells. Finally in Figure 5.8F a high resolution image of an individual
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carbon-coated iron oxide NP is presented. The lattice structure of the particle is easily
observable.
Figure 5.8: Light micrographs (z-stacks) of A) HeLa Kyoto and B) Macrophage J7442
cells cultured in the presence of a 10 µg/mL nanoparticle dispersion (diameter 9.7 nm)
after an incubation period of 48h. The white lines indicate the cut views through each
z-stack that are displayed at the top and right side of the pointed focal plane. In panels
C, D and E TEM micrographs of the HeLa and Macrophages show that the incubated
cells take up particles and small clusters. In panel F a high magnification image of a
nanoparticle showing the crystalline structure inside a cell is presented.
Moreover, the TEM investigations of the uptake suggest that cells can indeed discrim-
inate between the sizes of two of the samples investigated: the data strongly suggests
that the 9.7 nm NPs, for both the HeLa cells and macrophages, are hardly internalized
after 12 hours incubation, whereas the 20.3 nm NPs are seen to be internalized in large
numbers by both cells. In order to improve our understanding in the NP internalization,
further experiments to test the uptake were conducted for 24 h incubation and a similar
trend is observed in that significantly fewer particles of the 9.7 nm NPs were internalized
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as compared to the larger ones. However, after 48 hours this difference is less distinct.
It is important to point out that the characterization data shows that all samples are
identical in all respects except diameter; this data strongly suggests that cells are indeed
able to discriminate between small size differences of NPs. The reason for the difference
is still not clear and needs to be further investigated in future studies. Representative
TEM images of the uptake studies are provided in Figure B4 and B5 in the Appendix.
5.3 Summary
When comparing our results with work from others it becomes apparent that there
seems to be differences between not only our samples but between those from different
research groups as a whole. For example, according to the obtained results the mouse
fibroblasts show no or low cytotoxicity effects when incubated with the NPs at a con-
centration between 1 and 10 µg/ml, whereas relatively high toxic effects are observed for
concentrations of 100 µg/ml. Other studies using mouse fibroblast cells show no toxicity
even at 500 µg/ml [327–329]. Another study evaluating the toxicity of superparamag-
netic iron oxide nanoparticles (SPIONs) on a human lung epithelial cell line showed low
toxicity for these particles in concentrations raging from 20 to 80 µg/mL. Others found
high toxicity levels at the same concentration on human fibroblast [330, 331]. This indi-
cates that the cytotoxicity of iron oxide NPs is dependent on multiple parameters. The
presented study here in which a set of three narrow diameter distribution samples and
a broader diameter distribution sample were investigated show little difference between
all four NPs samples. This indicates, that to some extent broad diameter distributions
(as used in studies by others) are unlikely the reason behind the discrepancies. Our
data show that the presence of clusters can affect cytotoxicity evaluations. Opposite to
the cytotoxicity tests, the uptake studies indicate a strong difference in internalization
for diameters between the 9.7 and 20.3 nm mean diameter samples. Moreover, TEM
investigations indicate that cells uptake both individual particles and smaller clusters.
In our four cell line study, some differences between cell lines were observed, and this
highlights toxicity variations can exist between different cell lines. Studies by Ying and
Hwang[273] found that while the nanoparticle size (10 and 50 nm) shows little effect
on toxicity, the surface coating can significantly alter cytotoxicity results. In short,
determining the cytotoxicity effects of iron oxide NPs is complex.

Chapter 6
Facile route to coat iron oxide
nanoparticles with few layer
graphene
Before moving forward with synthesis, characterization and biological evaluation of a
different nanoparticle system (namely nanographene oxide), a route to coat iron oxide
nanoparticles with graphene will be presented. The method described in this chap-
ter provides a step towards the controllable growth of graphene layers on iron oxide
nanoparticles.
6.1 Introduction
A wide variety of nanoparticles (NPs) are thought to have potential for biomedical
applications [332]. As mentioned in the chapter 4, amongst all the NPs, the class
NPs imbued with magnetic properties is of particular interest due to their potential as
units for combined diagnostic and therapeutic treatment. However, challenges remain to
reduce their toxicity and target them effectively to specific regions of the body [333, 334].
These problems are thought to be largely due to the direct contact of the particles
with an external biological environment, which can cause degradation of the NPs and
result in even more toxic products [335]. A promising way to overcome this problem
is to use different types of coatings that can also render these particles with new and
enhanced properties [336]. Some examples include polymers [337, 338], surfactants [339]
and proteins [340]. However, often these coating materials are unstable and do not
provide a homogeneous isolation of the NPs surface [341]. Hence, prior to the direct
biocompatibilization of NPs, it is important to use a stable and non-toxic coating that
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isolates the NP from the outside biological environment and ideally also serves as a
platform for further functionalization. To this end, sp2 carbon (graphene and few layer
graphene) coatings have gained much interest due to their physicochemical properties
that offer both covalent and noncovalent functionalization with disparate functional
groups. This helps make them dispersible in a physiological environment and therefore
even more biocompatible [342, 343]. Moreover, the graphitic coating can carry several
moieties, such as specific biomolecules that can ensure a targeted end in the organism,
for example, tumors [344, 345]. Finally the graphene coating ensures the long-term
stability of the core under biological environments since they are not in contact with the
external environment [346–348]. In this chapter we use iron oxide NPs also synthesized
using a colloidal chemistry route as introduced in chapter 4 and describe a way to coat
them with 1 to 12 graphene layers. Usually iron oxide NPs coated with graphene layers
are fabricated using chemical vapor deposition (CVD). In addition, other techniques
such as laser ablation and arc discharge are also used. A drawback of these techniques is
that they yield NPs with a broad diameter distribution and moreover, a relatively large
amount of impurities are present that are difficult to remove. An alternative technique
to synthesize iron oxide NPs is through colloidal chemistry. Colloidal based synthesis
can yield particles with a narrower size distribution and less byproducts that can be
more easily removed. In general the byproduct is a carbonaceous material that coats
the NPs, as for example shown for iron oxide NPs in reference [349]. In this study we
demonstrate how this carbonaceous byproduct (oleic acid) can be used advantageously
to be used as a source of carbon the formation of graphitic layers. Moreover we reveal
the graphitization process through in situ a TEM and ex situ investigations by annealing
the NPs in dynamic vacuum at elevated temperatures. Indeed, the annealing process
can alter the particle size and reduce them to iron providing an attractive means to
tailor the magnetic properties of the particles. The magnetic properties of the NPs and
their potential as units for hyperthermia treatment were also investigated. Finally the
potential of oleic acid as a precursor for nano-graphene on alternative materials was
demonstrated on Si/SiO2 wafers.
6.2 Experimental
6.2.1 Synthesis of the iron oxide nanoparticles
The iron oxide nanoparticles in this section were synthesized in the similarly as described
in chapter 4. However, now the experimental setup is based in the work of J. Park [350],
which is now briefly explained. A typical procedure is based on the synthesis of an iron
oleate complex, which is the product of the reaction between iron chloride (III) (98%)
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and sodium oleate (99%) dissolved in a solvent mixture composed of ethanol, hexane
and distilled water. When heated for 4 hours on a hot plate the metal chloride and the
sodium oleate react to form a metal-oleate complex (iron oleate) and sodium chloride
(NaCl) (99%). The resulting mixture containing the iron oleate is then washed with
distilled water to remove all the salt byproduct and separated in a separation funnel.
The purified iron oleate complex presents itself in a waxy form, which is then used for the
thermal decomposition in a high boiling solvent. Prior to the thermal decomposition,
the purified iron-oleate complex is firstly dissolved in a mixture of oleic acid (90%) and
1-octadecene (90%) and heated to and then maintained at 320 ◦C in a reflux system for
30 minutes. The resulting solution, which contains the iron oxide crystals, is then cooled
down to room temperature. Ethanol and acetone were used to precipitate the crystals,
which were then collected using a strong magnet. The as-produced sample contains
iron oxide NPs with a mean diameter of 20.3 nm (±2.6 nm). The TEM shows that the
NPs are single crystals and the X-Ray Diffraction (XRD) pattern suggests a maghemite
phase (γ-Fe2O3). It is important to mention that magnetite NPs can also be present.
Typically the NPs have a coating of oleic acid over their surface which can be reduced
(but not eliminated) by multiple rinsing in chloroform. This surface coating of oleic acid
serves as the C rich pre-cursor for few-layer graphene coatings on the NPs. Oleic acid
has the formula CH3(CH2)7CH=CH(CH2)7COOH. It is classified as a monounsaturated
omega-9 fatty acid and occurs naturally in various animal and vegetable fats and oils.
6.2.2 Growth of graphene nanoflakes
Few layer graphene synthesis was also conducted on silicon wafers. To achieve this,
a very simple set of 3 steps were used to explore the formation of nano-graphene on
Si/SiO2 using oleic acid as the precursor. Step (i): Spin coat oleic acid onto small
pieces of Si/SiO2 wafer (0.5x0.5 cm
2 with an oxide layer of 100 nm). Step (ii): The
spin-coated substrate was then covered with another clear SiO2 wafer piece and then
(iii) the sandwiched sample was annealed in vacuum at 500 ◦C for 720 minutes.
6.2.3 Sample characterization
The samples were characterized using a variety of techniques. In order to determine the
mean diameter of the NPs a transmission electron microscope working in low voltage
mode operating at 80 kV (JEOL 2010 retrofitted with two third order Cs aberration
correctors) was used. Current densities up to 100 A/cm2 are possible. The sample was
imaged in different regions and the diameter for 100 individual particles was measured
at least 4 times for each particle and then averaged. An x-ray diffractometer (model
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Rigaku Miniflex) was used to investigate the crystalline structure of the NPs. In addition
the obtained XRD pattern was used to estimate the average crystal size according to the
Scherrer equation shown in equation 5.1. The average diameter (Dhkl) of the sample was
calculated to be 18.3 nm which is in agreement with the average particle size measured
using LVTEM. Table 6.1 summarizes the values found using the TEM (see Figure C1 in
Appendix C) and the Scherrer equation.
Table 6.1: Comparison between TEM and Scherrer mean diameter of NPs.
Annealing time [min] TEM diametera [nm] Scherrer diameter [nm]
0 19.1 (±2.6) 18.3 (±9.2)
15 18.5 (±2.4) 14.6 (±7.1)
60 27.9 (±2.5) 21.0 (±7.9)
720 33.8 (±2.9) 23.2 (±5.2)
aThe TEM diameter shown is only from the iron oxide core. In order to have the total
particle diameter one should add a value of 2.5 nm average coating to these values.
(See Figure C2 in Appendix C)
The presence of sp2 carbon was studied using Raman spectroscopy (model Thermo Sci-
entific DXR, laser λ = 532 nm). Table 6.1 summarizes the results obtained by TEM
and the Scherrer equation. To examine the different nanoparticle samples they were
pressed on Si/SiO2 wafers. The few-layer graphene nanoflakes were synthesized on
the Si/SiO2 wafers and therefore studied directly. The heating experiments were per-
formed in purpose built equipment with an operating frequency of 60 Hz. The samples
were dispersed in an aqueous solution using a tip sonicator in with a concentration of
5 mg/ml and measured over 4 minutes. Finally, the atomic force microscope (AFM model
Digital Instruments Veeco, NanoScope IIIa) was used (in tapping mode) to measure the
topographic features of the graphene nanoflakes and extract the average diameter and
height (number of layers) of the nanoflakes.
6.3 Results
6.3.1 In situ graphitization of oleic acid on iron oxide NPs
Colloidal chemistry is an ideal approach with which to synthesize iron oxide nanoparti-
cles with a well-defined diameter distribution [350, 351]. One of the drawbacks of the
technique is the fact that some residual reactant material always remains as a coating
on the produced nano-particles. In order to use this coating advantageously we decided
to explore the possibility of using it as a carbon source to form a graphitic coating.
Graphene of few-layer graphene coatings are stable, are impermeable and provide a
wider spectrum of possibilities for additional functionalization [347, 352]. In this study
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we demonstrate two graphitization approaches, namely, electron beam driven graphiti-
zation in-situ in a low voltage Cs aberration corrected transmission electron microscope
(LVTEM) and thermal driven graphitization under dynamic vacuum. We first discuss
graphene layer formation of oleic acid coated iron oxide nano-particles through an in
situ investigation in which individual iron oxide NPs coated with oleic acid are exposed
to an 80 keV LVTEM electron beam. In general, carbon based materials are sensitive
to a variety of irradiation effects, namely, electronic excitations and radiolysis, knock-
on displacements and radiation induced diffusion [353]. These processes enable carbon
based materials to decompose or crack forming amorphous carbon. Exposure of amor-
phous carbon to the electron beam leads to the formation of sp2 carbon, usually in the
form of carbon onions if the amorphous carbon is freestanding [354]. Typically this is
achieved with acceleration voltages above 100 keV however, we have recently shown this
is also possible using acceleration voltages of 80 kV [355]. The graphitization process
is generally accepted to occur through radiation induced diffusion [356] which can be
thought of qualitatively to be similar to thermal diffusion. Figure 6.1A to F show a
series of consecutive images of the in-situ graphitization of oleic acid coatings. In panel
A an iron oxide initially coated with oleic acid is seen. In consecutive frames the coating
thickness is seen to increase from ∼2.9 nm to ∼3.5 nm, moreover the coating is seen
to form in to a layered structure with the layers forming parallel to the surface of the
NP (see panel G). The layers look much like graphene layers and have an interlayer
spacing of 0.35 nm which is commensurate with graphene layers (panel H). The fact the
layers form parallel to the core nanoparticles surface rather than form carbons onions is
attributed to van der Waals forces helping drive planar graphitization in keeping with a
recent study of ours [355].
We also observed that there is a relationship between the thickness of the fatty acid
layer and the number of layers that can be formed. Panels A to F in Figure 6.2 show 3
different NPs with different thicknesses of their initial oleic acids outer coating (panels A,
C and E) and their corresponding graphitic coating (panels B, D and F). The oleic acid
coating thickness is easily controlled in the post production stage by repeated washing in
chloroform. The greater the number of washing steps the thinner the oleic acid coating
is. However, a threshold is reached in which a very thin surface layer always remains,
presumably because of strong van der Waals interactions and possibly chemical bonding
to surface atoms, although this latter scenario is less likely. The controlled oleic acid
coating varies from 0.7 nm to 4 nm. These oleic acid coatings result in graphene layer
coatings ranging from 1 to 2 graphene layers through around 12 layers. The reaction
time to form graphene layers on the surface of the NPs increases as the oleic acid coating
thickness increases and is presumably related to diffusion lengths of C species.
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Figure 6.1: Panels A through F show the stepwise in situ graphitization of oleic
acid coatings on iron oxide nanoparticles in LVTEM under electron irradiation. The
time elapsed between panels A and F corresponds to an electron beam exposure of 3.5
minutes. Panel G shows a higher magnification of the particle in panel F with a fully
graphitized coating particle after electron beam irradiation. Panel H a zoomed area
from panel G depicting the spacing between the shells (0.35 nm) is shown. The spacing
corresponds to multilayer graphene coating.
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Figure 6.2: Examples of 3 different oleic acid thickness coating iron oxide particles
after minimal (panels A, C and E) and extended (B, D and F) electron irradiation
respectively. Panel G shows the resultant number of graphene layers (after electron
irradiation) and the irradiation time for full graphitization with respect to the initial
oleic acid coating thickness.
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6.3.2 Bulk graphitization of oleic acid on iron oxide nanoparticles
While the in-situ LVTEM graphitization route interesting it is not practical for the
large scale production of graphitic coated NPs. To overcome this issue we explored the
potential of annealing the samples under high vacuum (∼10−6 mbar). The samples were
annealed at 500 ◦C for a variety of different time intervals, 15, 45, 60, 120 and 720 min.
LVTEM investigations were implemented to investigate how the annealing procedure
alters the coating and morphology of the particles. Typical examples are presented
in Figure 6.3. Generally the mean diameter of the particles increases with increasing
annealing time as illustrated in the graph shown in panel G of Figure 6.3. The increase
in nano-particle size is probably due to sintering [357]. The mean diameter of the NPs
was estimated from TEM micrographs for at least 100 particles. In addition the surface
of the particles shows few-layer graphene, even after 15 min. annealing. Analysis of
the interlayer spacing of the graphitic coating from thermally annealed samples did not
differ from the measured in situ value, which further suggests that the parameter chosen
to anneal the samples were sufficient to reproduce the results obtained in the in situ
study. Some examples are shown in panels E and F of Figure 6.3.
Raman spectroscopy is powerful technique to identify sp2 carbon, especially through the
first order peaks around 1350 cm−1 and 1600 cm−1, which are termed the D and G band
respectively. The D band arises due to breathing modes of sp2 atoms in rings but is only
active when symmetry is broken (e.g due to a defect) due to its peculiar selection rules
and the G band arises through bond stretching of all sp2 carbon pairs in both rings and
chains [358]. The intensity ratio of the D/G modes is often used as an indicator how
crystalline the graphitic material is. Thus it is of interest to use Raman spectroscopy
to investigate our samples as a tool to help elucidate the graphitization of the oleic
acid coating on our iron oxide nano particles. To minimize any graphitization by the
excitation laser very low laser powers (less than 3 mW) were used along with short
collection times. The D/G intensities ratio relative to the peak area for the pristine
sample (oleic acid coating) was ca. 3.5 while for the annealed samples it reduced to
between 1 and 2, indicating improved crystallisation. Moreover the D and G modes were
more defined as illustrated in Figure 6.4 panel A. These changes in the D/G modes are
concomitant with the graphitization of the fatty acid coating. X-ray diffraction (XRD)
was used to indicate if any structural changes had occurred for the core particles. After
15 minutes little to no changes are observed. For longer annealing periods, new peaks
begin to emerge and old peaks diminish such that by 720 minutes the XRD pattern
no longer matches iron oxide, but matches that of pure iron (see panel B in Figure
6.4). This tells us the iron oxide nanoparticles chemically reduce with the annealing
process. Presumably the oxygen leaves by forming carbon monoxide or dioxide species.
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Figure 6.3: Panels A through E show the nanoparticles after different annealing
periods (0, 15, 60, 120, 720 minutes respectively). Panels E and F show graphitic
layers around the nanoparticles after thermal annealing. The annealing period for the
nanoparticles was 60 and 720 minutes, respectively. Panel G shows the change in
particle mean diameter with respect to annealing time.
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No evidence for iron carbide was observed. To further confirm the XRD data, analysis
of the crystalline lattice from TEM data was conducted (see Figure C3 In Appendix
C). The data correlated very well with the XRD findings. The gradual change in phase
of the nanoparticles from iron oxide to iron is also visible in the magnetization data.
Panel C in Figure 6.4 shows the magnetizations curves M(H), at 300 K. Only a small
change in the saturation magnetization is observed for the sample annealed for 15 min
as compared to the pristine sample (from 50 to 65 emu/g). However for the samples
annealed for 60 and 720 min the saturation magnetization goes up to 130 emu/g and
200 emu/g respectively. In addition there is an increase in the coercivity with annealing
time which may be both due to an increase in particle size as observed in the LVTEM
studies and a reduction of the iron oxide cores to Fe. This increase in the coercivity
(HC) with respect to the annealing time varies from 22 Oe in the as-synthesized particles
to around 200 Oe in the 720 minutes annealed samples. In the literature the coercivity
values of Fe nanoparticles with the same size diameter range have been reported to vary
dramatically between samples [359, 360]. The reason for these differences in coercivity
is not clear, but we suspect that the synthesis route or the annealing process could
lead to different impurities and/or Fe ratios, leading to samples with different Hc. This
has already been observed in Fe-filled carbon nanotubes [361] and composite NPs [362].
One can extrapolate the ratio of magnetic material to non-magnetic material from the
saturation magnetization data. For the pristine material on obtains a mass percentage
of 72% for γ-Fe2O3 (with bulk MS(γ−Fe2O3) = 74 emu/g) while the rest is nonmagnetic,
i.e. diamagnetic organic material (C) or, e.g., a small amount of α-Fe2O3 not detected
in the XRD data. For samples annealed for 720 min a pure Fe core is obtained as
indicated from the XRD data. In addition to the chemical reduction of iron oxide with
annealing the relative amount of non-magnetic materials in the sample also decreases
since for the annealed sample one extracts 94% mass of Fe and 6% of carbon (with bulk
MS(Fe) = 214 emu/g) [363]. For intermediate annealing levels, only rough trends can
be deduced from the magnetization data since the core do not consist of a single pure
phase (only partial chemical reduction has occurred). Crudely, if one assumes 28% of
the mass as C, a saturation magnetization of 133 emu/g implies 30%of Fe and 42% of
γ-Fe2O3, which is consistent with the XRD pattern. Less carbon would imply more
γ-Fe2O3. The magnetisation curves shown in Figure 6.4 Panel C imply that at least
a part of the pristine particles are blocked at room temperature, which is in keeping
with the critical blocking radius at 300 K occurring near that of the mean particle size
for the pristine sample [364]. Upon annealing, the material converts to pure iron which
exhibits a slightly higher anisotropy, which again agrees to the observation of increasing
HC . This implies that even after 15 min annealing there is already significant change in
the core material. Concomitantly, however, there seems to be a general trend of slightly
increasing core diameters which also would yield an increase of HC in this size range, so
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that no clear quantitative estimates can be made. The change in phase from iron oxide
to pure iron in essence provides a means to tailor the magnetization saturation which
can be attractive for hyperthermia treatment, since higher saturation magnetization
translates to more efficient heating. In short, in hyperthermia treatment, magnetic
nanoparticles subjected to an alternating magnetic (AC) field produce heat that may be
related to several physical mechanisms. In ferromagnetic particles, the magnetization
reversal is usually described by the hysteresis loop and the heating is caused by hysteresis
losses [365, 366]. In superparamagnetic particles, relaxation losses may be associated
with rotation of the particle itself. Both the Brownian and Néel relaxation lead to a
dissipation of energy which leads to heating of the local environment. In hyperthermia
the idea is to use this heat (from both Brownian and Néel relaxation) to destroy cancer
cells. Cancer cells are vulnerable to heat and so if magnetic nanoparticles are attached
or taken up by cancer cells and then exposed to an alternating magnetic field the cancer
cells, which do not have the ability to endure the damaging effects of increased heat
levels, will eventually die. The power dissipated by magnetic materials whilst under the
influence of an alternating magnetic field is known as the specific absorption rate (SAR)
and is expressed as power per unit mass (W/g) [367, 368] presented in equation 3.2.
Here again c is the specific heat capacity, which in the case of water is c=4.118 J.g−1K−1
and mact is the mass of magnetically active material. To evaluate the hyperthermia
potential of our nanoparticles, they were dispersed in an aqueous solution of 5 mg/ml
and then subjected to an alternating magnetic field varying from 10 to 80 kA/m. The
results are shown in Figure 6.4 panel D. The data shows an increased SAR for the
annealed samples relative to the pristine samples. Notably the samples prepared by
annealing for 720 min heated the solution from room temperature to 50 ◦C in under
2 min. for an alternating magnetic field of 80 kA/m. (see Figure C4 in the Appendix
C) In order to compare the results quantitatively with literature data, we normalize the
data in Figure 6.4 D to the mass of the magnetic core material only as determined by
the magnetisation study. For the pristine and fully reduced samples we find SAR =
262 W/gγ−Fe2O3 (SAR normalized to the total mass = 210 W/gγ−Fe2O3@C) and 566
W/gFe (SARtotal = 520 W/gFe@C), at H = 80 kA/m respectively. For comparison, a
recent study on commercial Fe@C nanoparticles with an average diameter of 25 nm was
shown to have a SAR value up to 240 W/gFe@C [331]. Reported SAR values of of Co@C
and Ni@C synthesized using a chemical vapor deposition (CVD) route were 162 W/g
and 131 W/g respectively. In essence, these published values for Fe, Co and Ni coated
with carbon are comparable to our pristine material. However, our fully reduced sample
exhibits a SAR value twice as good. We also calculated the intrinsic loss power (ILP)
[369] for the samples given by
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ILP =
SAR
H2.f
(6.1)
where H is the alternating magnetic field and f is the AC field frequency, which in our
case is 120 kHz. This yields ILPγ−Fe2O3 ∼ 3.41x10−4 nH.m2 and ILPFe ∼ 7.36x10−4
nH.m2/gFe for the pristine and fully reduced samples, respectively. These values com-
pare favorably with results from another recent study on Co@C with 57% mass of Co
and a mean core size of 9 nm from which an ILPCo@C ∼ 3x10−4 nH.m2/gCo@C (ILPCo
∼ 5.3x10−4 nH.m2/gCo) was obtained [341]. The data highlight the potential to tailor
the magnetic performance of iron oxide nano-particles coated with few-layer graphene
layers by chemical reduction through annealing. Moreover the magnetic data compare
favorable with other Fe@C, Co@C and Ni@C samples discussed in the literature.
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Figure 6.4: Panel A depicts the Raman spectra for the starting iron oxide nanopar-
ticles and particles after thermal annealing for 720 minutes. Panel B shows the XRD
spectra for the corresponding samples used in A. It shows that already after 15 min-
utes annealing some structural changes starts depicted by the arrow. The dashed circle
suggest that after 60 minutes annealing there might have some iron oxide left in the
sample as some peaks corresponding to maghemite can be seen, as also observed in the
analysis of the crystalline lattice of individual particles (see Figure C5 in the Appendix
C). A magnified region highlighting the greatest changes is available in Figure C3 in
the Appendix C. Panel C shows the hysteresis curves for the samples after various an-
nealing times. Inset: maximum Ms for each sample versus annealing time (curve is a
guide to the eye). Panel D provides specific absorption rate (SAR) for different field
strengths for the various annealed samples.
6.3.3 Graphitization of oleic acid on a Si/SiO2 substrate
In order to further investigate the graphitization potential of oleic acid on alternative
materials, a simple experiment was conducted. Firstly, small pieces (5 mm x 5 mm)
of clean Si/SiO2 wafers were spin-coated with oleic acid and annealed in high vacuum
at 500 ◦C for 720 minutes. Annealing experiments were conducted two ways. In the
first a single a wafer was annealed and in the second experiment a second Si/SiO2
wafer was placed face down on the first wafer so as to sandwich the oleic acid film
between the two SiO2 faces of the wafers. In the first experiment no evidence for sp
2
carbon was observed from atomic force microscopy (AFM) and Raman spectroscopy
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investigations. Presumably the oleic acid decomposes and desorbs from the surface.
In the second type of experiments, Raman spectroscopy showed the presence of sp2
carbon. AFM showed the presence of flakes on the surface indicating that large area
graphitization does not occur, but rather, small domains form (see Figure 6.5 panel
A). The domains diameters range from 100 nm to 250 nm and their heights range
from 1.5 nm to 2.5 nm, which in terms of the number of graphitic layers (assuming an
interlayer spacing of 0.35 nm) is 4 to 7 layers. The average diameter and height was
164 nm and 2.0 nm (5-6 layers) respectively (see Figure C6 in the Appendix C). To
confirm the nature of the flakes they were transferred on to lacey carbon TEM grids and
studies in LVTEM. The LVTEM studies confirmed the presences of flakes (e.g. Figure
6.5 panel B). Closer examination showed Moiré patterns indicating the graphitic layers
are turbostratic (panel C in Figure 6.5). Looking at the Fourier domain shows multiple
sets of hexagonal reflex spots confirming the presence rotational stacking faults between
the graphene layers [342]. The Raman spectrum of the sample showed the characteristic
D and G modes confirming the presence of sp2 carbon (See Figure C7 in the Appendix
C). The spacing corresponds to the graphene lattice constant, again, confirming the
formation of few layer graphene islands.
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Figure 6.5: Panel A shows AFM images of few-layer graphene flakes residing on
Si/SiO2. The inset shows a higher magnification of a single flake. Panel B shows
a LVTEM image of a flake. Panel C shows a higher magnification of a flake. The
Moiré pattern indicates the multi layer graphene is turbostratic. Panel D shows the
Fourier domain (from panel C) multiple sets of hexagonal reflexes corroborate rotational
stacking disorder, viz. turbostratic few layer graphene.
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6.4 Summary
To summarize, the section 4.2 of this chapter highlighted the potential of converting
oleic acid coatings on iron oxide nano-particles into sp2 carbon has been successfully
demonstrated. The graphitization process was shown both in situ and ex situ using
either electron irradiation or thermal annealing respectively. The data show a direct
correlation between the initial oleic acid coating and the resultant number of graphene
layers coating the particles. Thermal annealing reduces the iron oxide toward pure
iron and the particles coalesce leading to larger average particles sizes. Both these
aspects lead to enhanced magnetic properties and thus provide a means to tailor the
magnetic properties. The magnetic properties compare very favorably against similar
nano-particles discussed in the literature. The potential of the few-layer graphene coated
particles for hyperthermia was demonstrated through specific absorption rate studies.
The graphitization of oleic acid was also shown on Si/SiO2 wafers. By sandwiching an
oleic acid film in between two Si/SO2 wafers small few layer graphene flakes consisting
of 4 to 7 layers could be formed by simply annealing in high vacuum.
Chapter 7
Characterization and biological
evaluation of nanographene oxide
nanoparticles
The seventh chapter of this work is divided into two main sections. The first one
is dedicated to the characterization of the nanographene oxide samples introduced in
section 4.2. The second section is dedicated to the investigation of the cytoxicity and
the uptake of the two different sizes of nanographene oxide nanoparticles.
7.1 Sample characterization
7.1.1 Experimental
The characterization of the nanographene oxide samples (synthesis shown in section
4.2) were performed using a variety of techniques. In order to obtain information about
the diameter distribution of the nanographene flakes, a droplet of the aqueous solution
containing the NGO was dried on a clean Silicon (Si) wafer. The Si wafer containing the
NGO was then observed in the scanning electron microscope (FEI NOVA NanoSEM200).
The images containing the flakes were then analyzed with statistical methods. For each
sample, more than one hundred particles were measured at least four times each. The
average of the measurements was taken as the mean diameter of the flake. Hence it
was possible to plot the size distribution of each sample. In order to obtain the average
number of graphene layers, the same Si wafers carrying the NGO were measured using an
atomic force microscope (Digital Instruments Veeco, NanoScope IIIa) operating in the
tapping mode. In this case it was possible to obtain information about the topography of
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the sample, namely the height of individual NGO flakes. Since it is known that the space
between individual layers is approximately 0.35 Å, if is possible to estimate the number
of layers in each measured flake and hence also plot a distribution. In this case each
individual flake was measured at least four times for over one hundred particles. These
measurements were then averaged. The presence of sp2 carbon was confirmed using
Raman spectroscopy (Thermo Scientific DXR, laser λ = 532 nm), while the presence of
functional groups was confirmed by the use of Fourier Transform Infrared spectroscopy
(Bruker IFS 113 spectrometer) and X-ray photoemission spectroscopy equipped with a
hemispherical electron analyzer SPECS PHOIBOS 100.
7.1.2 Results
The statistical evalution of size and number of graphene layers was already presented
in chapter 4. Two different sizes of nanographene oxide were synthesized. One sample
containing flakes with a mean diameter of 89 nm and 6 layers and another sample
containing flakes with 277 nm diameter and 4 layers. For more details in the size and
number of layers distributions see Figure D1 in Appendix D. The presence of sp2 carbon
hybridization was confirmed by the Raman spectroscopy shown in Figure 7.1 panel A.
In the Raman spectroscopy it is possible to see the presence of the D, G and 2D modes,
which are characteristic of graphene. The presence of a large D mode indicate that
the graphene flakes were very defective. This is expected since the initial graphite was
oxidized and different functional groups were inserted both on the basal planes and
edges of the nanographene flakes. The presence of functional groups were confirmed
using Fourier Transform Infrared Spectroscopy (FTIR). The IR spectra can be seen in
Figure 7.1 panel B and present a variety of functional species. The most characteristic
groups show peaks at 750, 1700 and 2225 cm−1, which correspond to C-O, C-H and
C=O groups, respectively.
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Figure 7.1: Panel A shows the Raman spectra of both NGO sizes. The spectra show
clear presence of D and G modes. The 2D mode is also possible to identify. Panel
B shows the IR spectra of both NGO samples and suggest the presence of different
funcitonal groups, confirming that the oxidation of the initial graphite material was
accomplished.
In order to check the presence of contaminants or undesired materials, EDX measure-
ments of individual flakes were performed when observing individual nanographene oxide
flakes in the TEM (see Figure D2 in Appendix D). The EDX data only shows the pres-
ence of Carbon (C) and Oxygen (O). The presence of Copper (Cu) is due to the TEM
Copper grids used. The XPS data was conducted in an ultrahigh vaccum atmosphere.
In Figure 7.2 it is possible to see the XPS spectra of the nanographene oxde samples
for the C 1s (Figure 7.2A) and for the O 1s (Figure 7.2B). For the C 1s spectra, the
deconvolution of the peaks revealed components corresponding to different functional
groupsat 284.4 , 285.1, 286.8 and 288.6 eV, which correspond respectively to sp2 carbon,
hydroxylic, epoxy, carbonyl and carboxlyic functional groups. The O 1s plots spectra
were also deconvoluted and showed peaks centered at 531.3, 533.3 and 535.1 eV, which
correspond to carboxylic, epoxy and hydroxylic functional groups. Both the C 1s and
the O 1s XPS spectra show similiar functional groups and are complement to each other.
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Figure 7.2: Panel A shows the C 1s XPS spectra of both NGO sizes (89 and 277 nm)
and panel B shows the O 1s XPS spectra of both NGO sizes (89 and 277 nm).
The XPS data shown in Figure 7.3 panels A, B and C reveal the presence of Sufur (S),
Sodium (Na) and Chlorine (Cl), respectively. The presence of these elements is assigned
to the initial synthesis process, which used substances containing these elements. As
mentioned in the methods to synthesis the graphene oxide in chapter 4, the samples were
rinsed abundantly with distilled water in order to remove unwanted byproducts from the
oxidation reaction. However even with intense rinsing some of these by products might
penetrate in between the graphene layers and remain trapped inside. This problem that
cannot be avoided by using this synthesis procedure. In this case the contaminants offer
no risk since they do not get free in the environment.
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Figure 7.3: Panel A shows the S 2p XPS spectra of both NGO sizes (89 and 277 nm),
panel B shows the Cl 2p XPS spectra of both NGO sizes and panel C (89 and 277 nm).
7.2 Cytotoxicity and uptake studies of nanographene oxide
The biological assays described in chapter two were used to perform the cytotoxicity
tests.To test the metabolism of the cells the MTT assay was used, whereas to directly
assess the cell death the trypan blue assay was used. The internalization studies were
performed using a TEM after the samples were accordingly prepared for this purpose.
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7.2.1 Experimental
Cell culture: The biological tests were done for two different cell lines: HeLa cells (Kyoto
line) and macrophages J7442 cell. The HeLa cells were cultured in DMEM+GlutaMAXTM
(gibco) supplemented with 1% NEAA (gibco); macrophage J7442 cells were grown in
DMEM F12HAM supplemented with 2 mM l-glutamine (Sigma-Aldrich). Additionally
all the media contained 10% FBS (Sigma-Aldrich), 100 U/mL penicillin and 100 µg/mL
streptomycin (gibco). To create a cell suspension the cells were washed once with PBS
(gibco) and detached using a cell scraper for the macrophages (Greiner Bio-One) or for
the other cell line, 0.25% Trypsin-EDTA solution (Sigma).
MTT viability assay : For cell viability studies, a commercial TOX-1 in vitro toxicology
assay kit (Sigma-Aldrich) was used. The assay measures the viability of living cells via
the cleavage of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) to
purple formazan crystals by the cells’ mitochondrial dehydrogenases. Two different cell
lines were grown in standard 96 well flat-bottom plates as testing systems and 5.0x103
cells per well were tested. The NPs were suspended in DI water at a stock concentration
of 0.5 mg/mL. To assure a uniform dispersion of the particles the suspensions were
vortexed (stirred) on a Vortex Genie 2T for 2 min prior to usage. After incubating the
cells at 37 ◦C and 5% CO2 in the presence of increasing concentrations of NPs (controls
with only DI water, 1 µg/mL, 10 µg/mL and 100 µg/mL) for either 12 or 48 h, 10 µL of
the MTT solution (5 mg/mL in PBS) was added to the 0.1 mL culture medium per well
and the 96 well plates were returned to the incubator for another 4 h. After carefully
removing 80 µL of the supernatant the produced formazan crystals were then dissolved
in 0.1 mL of the prewarmed MTT Solubilization Solution (10% Triton X-100, 0.1 M
HCl in anhydrous isopropanol) by gently shaking the plates in an ELISA microplate
reader (15 min, 14 Hz, 37 ◦C, SAFAS MP96). The absorbance of the formazan dye
was measured in the SAFASMP96 reader at 550 nm/650 nm within an hour and after
having substracted the background from the sample, the percentage cell viability was
calculated. Each of the conducted experiments was repeated three times.
Dye exclusion test (Trypan Blue): The cell lines were grown in standard 6 well flat-
bottom plates and incubated for 12 or 48 h with the respective nanoparticle suspension
at a concentration of 10 µg/mL. Afterwards the cells were detached and resuspended
in 1 mL cell culture Medium per well. 20 µL of each cell suspension were carefully
mixed with 0.4% trypan blue solution (Sigma) and added to the chambers of a standard
hemocytometer (improved Neubauer) to count the number of viable and dead cells. The
results are presented as means of two measurements each and their deviation.
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TEM investigations: The cells were grown as a monolayer in a humidified incubator in
the conditions described above. The cells were seeded in a 6 cm petri dish for 4 h prior
to the incubation with the NPs. After this adhesion period the bottom the cells were
treated with the NPs in a concentration of 10 µg/ml for a period of 48 h. The cells
were collected from the culture dish and centrifuged at 1000 rpm for 5 min, and the
supernatant was removed. The cell pellets were fixed in a 2.5% gluteraldehyde for 4 h.
They were then rinsed with PBS, embedded in 4% agarose gel, a second fixation step
was conducted in 2% osmium tetroxide solution for 24 h and then rinsed with distilled
water. The samples were stained with 1% uranyl acetate for 1.5 h, dehydrated in a
graded series of acetone (25, 50, 75, 96 and 100%), and embedded in epoxy resin. The
resin was polymerized firstly for 3 h at 50 ◦C and then the temperature increase to
60 ◦C for 48 h. Ultrathin sections (50–70 nm) obtained with a ultramicrotome and
imaged using transmission electron microscope (TEM) JEOL 2010F retrofitted with
two third order Cs aberration correctors operating at 80 kV and a FEI TECNAI T20
operating at 200 kV.
7.2.2 Results
The size dependent cytotoxicity of the nanographene oxide NPs was investigated. Two
different cell lines (HeLa Kyoto and macrophages (J7442)) were incubated with the
NPs dispersed in water at three distinct concentrations (1, 10 and 100 µg/ml) for a
period of 12 and 48 h. In order to quantify the toxicity of the different NPs two dif-
ferent approaches were used. Initially, the number of viable cells was measured with a
colorimetric assay that is based on the reduction of yellow MTT (3-[4,5-dimethylthiazol-
2-yl]-2,5-diphenyltetrazolium bromide) to purple formazan crystals by mitochondrial
dehydrogenase enzymes. The cleavage of MTT occurs only in living cells so that the
amount of the produced formazan crystals is proportional to the number of living cells.
In addition, to exclude the possible influence of the NPs on the test results, cell-free
tests were simultaneously conducted. As mentioned before in chapter 5, the MTT assay
does not provide any information as to whether the NPs themselves cause cell death or
whether they simply reduce the cellular metabolic activity. Hence we implemented a
second approach, the dye exclusion method with trypan blue. The cell viability assay is
based on the exclusion of the blue dye from healthy cells. In dead cells the membrane
is no longer functional (ruptured) and the dye is able to cross the membrane, staining
the cell interior. Using a visible light microscope, the dead cells are observed to be dark
blue instead of bright.
MTT assay : Like for the iron oxide nanoparticles, the MTT assay was initially per-
formed for an incubation period of 12 hours. The data from the MTT assay of this
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short-exposure time for the HeLa cells and macrophages are provided in Figure 7.4A
and C, respectively. The data for the 48 hours incubation period are shown in Figure
7.4B and D also for the HeLa cells and macrophages, respectively. The sample contain-
ing NGO nanoparticles with 89 nm diameter incubated with HeLa cells for 12 hours
showed no strong difference in the viability for the all concentrations used, whereas for
the sample with 277 nm, the viability for the 10 and 100 µg/ml tests abruptly decreases.
When the same set of data is compared with the incubation period of 48 hours it is
possible to see that for both the 89 and 277 nm samples the viability decreases with
increasing concentration. This suggests that for shorter incubation periods the bigger
flakes are inducing a higher toxicity in HeLa cells and when the incubation period is
increased the toxicity is similar for both sizes. The same comparison described above
was done for the macrophages (Figure 7.4C and D) and it was possible to notice that the
same trend. The data suggest a size dependence on the toxicity for the shorter incuba-
tion periods in both cell lines, whereas for longer incubation periods the concentration
of the material seems to play a more important role than the size of the nanoparticles
used.
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Figure 7.4: Panels A and B show the MTT test results using the HeLa cells incubated
for 12 h and 48 h with both NGO samples, respectively. Panels C and D show the
MTT test using macrophages incubated for 12 h and 48 h with both NGO samples,
respectively. The MTT tests show that the NGO at higher concentrations reduces the
viability of all cell lines. The 89 nm NGO incubated only for 12 h does not show any
significant reduction in viability for both cells lines, whereas the 277 nm NGO reduces
the viability for all incubation periods. This suggests that there is a correlation between
size of the nanoparticle and incubation period.
Dye exclusion assay (Trypan blue assay): The dye exclusion test (trypan blue) was also
conducted for both sizes of nanographene oxide (89 and 277 nm). In Figure 7.5 the
results obtained for both cell lines incubated with the nanoparticles at a concentration
of 10 µg/ml are shown. Both the HeLa cells and the macrophages do not present a
decrease in viability. This indicates that the cells incubated with the nanographene
oxide nanoparticles tend to undergo a reduction in mitochondrial activity (indicated by
MTT assay) rather than die as indicated by the trypan blue assay in Figure 7.5A-D.
This result was comparable to the same tests performed with the iron oxide nanoparticles
coated with graphene described in chapter five.
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Figure 7.5: Panels A and B show the trypan blue test for the HeLa cells incubated for
12 h and 48 h with both NGO samples, respectively. Panels C and D show the trypan
blue test for the macrophages incubated for 12 h and 48 h with both NGO samples.
The trypan blue tests show that the NGO do not cause cell death, which suggest that
the nanoparticles only reduce the mitochondrial activity of the cell.
7.2.3 Uptake studies
The uptake of the nanographene oxide nanoparticles was investigated using TEM. The
TEM studies were conducted for the two cell lines incubated with NPs at a concentration
of 10 µg/mL. In Figure 7.6A and B it is possible to see that the HeLa cells incubated
with the 89 nm NPs for 12 and 48 hours, respectively, whereas in Figure 7.6C and D
it is possible to see the HeLa cells incubated with the 277 nm NPs incubated for 12
and 48 hours, respectively. The HeLa cells internalized both nanographene sizes and
no conclusive information about differences in the amount of nanoparticles internalized
could be obtained.
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Figure 7.6: In A and B it is posible to see the TEM images of the HeLa cells incubated
with the 89 nm for 12 and 48 h, respectively. In C and D it is possible to see the HeLa
cells incubated with the 277 nm for 12 and 48 h, respectively. In the TEM images it is
possible to see that both sizes are internalized by HeLa cell as depicted by the arrows.
In Figure 7.7 panels A and B it is possible to see that the macrophages incubated with
the 89 nm NPs for 12 and 48 hours, respectively, whereas in Figure 7.7C and D it
is possible to see the macrophages incubated with the 277 nm NPs incubated for 12
and 48 hours, respectively. Like for the HeLa cells, the macrophages internalized both
nanographene sizes, however no conclusive information about differences in the amount
of nanoparticles internalized could be obtained.
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Figure 7.7: In A and B it is possible to see the TEM images of the macrophages
incubated with the 89 nm for 12 and 48 h, respectively. In C and D it is possible to see
the macrophages incubated with the 277 nm for 12 and 48 h, respectively. In the TEM
images it is possible to see that both sizes are internalized by HeLa cell as depicted by
the arrows.
7.3 Summary
The toxicity data conducted using the nanographene oxide nanoparticles and different
cell lines (HeLa cells and macrophages) suggest that for the incubation time of 12 hours
the small flakes (89 nm) show no difference for the concentrations used (1, 10 and 100
µg/mL), whereas the bigger flakes (277 nm) present for the same incubation period a
reduction in viability for the highest concentrations used (10 and 100 µg/mL). When the
nanographene oxide nanoparticles are incubated for 48 hours with the cell lines, both the
HeLa cells and the macrophages present a decrease in viability when the concentration of
NPs is increased. In this case of a longer incubation period, the sizes of the nanographene
oxide seem to have no influence in the reduction of cell viability. The TEM investigations
showed that the nanographene oxide NPs are internalized by all cell lines and incubation
periods. Moreover, no difference in the uptake could be observed between the different
sizes of the NPs. More investigations need to be conducted in order to undertand when
the uptake of the NPs start to happen as well as if the uptake of the smallest (or the
biggest) nanoparticle size is internalized first than the other.
Chapter 8
Characterization and biological
evaluation of graphene nanoshells
The eighth chapter of this work is also divided into two main sections. The first one is
dedicated to present the characterization of the as-synthesized graphene nanoshells. The
second part of the chapter presents the cytotoxicity and uptake data of the graphene
nanoshells, which was done in collaboration with the Swiss Federal Laboratory for Ma-
terials Science and Technology (EMPA) in Switzerland.
8.1 Sample characterization
The shape of the shells varies with some being round and others cubed as can be seen in
Figure E1 in the Appendix E. This is due to the shape of the inner MgO nanoparticle
templates. EDX of all samples shown in Figure E2 in the Appendix E suggest no
contamination. Only carbon, traces of oxygen and copper are present. The copper
signal is from the TEM grid (see Figure E2 in the Appendix E). Raman spectroscopy
is a powerful tool with which to identify the presence of sp2 (graphitic) carbon and
thus provides an ideal means to confirm the layered material that formed over the
surface of the oxide nanoparticles is few-layer graphene. sp2 carbon provides two clear
signatures in Raman spectroscopy through the first order peaks around 1350 cm−1 and
1600 cm−1, which are termed the D and G band respectively. Stretching of all sp2
carbon pairs in both rings and chains leads to the so called G (graphitic) mode, while
breathing modes of sp2 atoms in rings lead to the D (defect) mode, since this mode is
only activated by defects due to its peculiar selection rules [370]. All samples prepared
in this study showed clear G and D mode signatures as for example shown in Figure
4.16 A. In general, the G to D mode ratios vary between 1.3 and 2 suggesting the
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graphitic material is rather defective. This may not necessarily be due to vacancies in
the graphene layers, but to the relatively large number of edges with dangling bonds
[371]. Fourier transform infra-red (FTIR) spectroscopy also showed the presence of C-C
stretch and hexagonal C modes between 500 cm−1 and 2000 cm−1 (data not shown).
In addition, the spectra showed weak responses corresponding to C-O and C=O stretch
modes. To better investigate the samples and the presence of oxygen based species, X-
ray photoelectron spectroscopy (XPS) was implemented (Figure 4.16 panels b through
f). Both the C@MgO and graphene nanoshells exhibited C1s edge profiles at around
284 eV corresponding to sp2 carbon (panel b in figure 2). The rear tail of the C1s edge
terminates at 287 eV and so does not preclude the (weak) presence of C-O and C=O
species. In the case of oxide nanoparticles coated with few layer graphene, the O1s edge
centers at ca. 531 eV which can be attributed to O adsorbents or carbonates. However,
the lack of any signal around 290 eV (carbonate signature) in the C1s edge indicates O
adsorbents dominate.
 
Figure 8.1: Upper panels: Representative spectra of graphene coated oxide particles
A) Raman spectrum of G and D region B) XPS spectrum of C 1s region, c) XPS
spectrum of O1s region and Lower panels: spectra of carbon shells after removal of
MgO with dilute HCl, D) XPS spectrum of Cl 2p region, E) XPS spectrum of C 1s
region, F) XPS spectrum of O 1s region.
This is in agreement with the EDX data indicating only a small O fraction and the
FTIR data demonstrating any contribution from C-O and C=O species is small. In the
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case of the hollow shell samples which were produced by treatment in HCl to dissolve
out the MgO core, the XPS spectrum deviates from that of the as produced samples
in that the O 1s peak is weaker relative to the C 1s edge. Moreover the O 1s edge
centers at around 533 eV which suggests the presence of C-O based species despite the
sample being annealed in high vacuum. This is concomitant with findings by others in
which annealing in vacuum does not fully remove oxygen based species (although surface
adsorbents are removed) [372]. In addition, Cl based species were observed (due to the
HCl treatment). The XPS data showed chlorine based species at around 200 eV and
210 eV which correspond to CxHyCl and HxClOy (perchlorate) species respectively. As
will be shown later, these Cl based species might influence the reactive oxygen species
toxicity test.
8.2 Cytotoxicity and uptake studies of graphene nanoshells
8.2.1 Experimental
Cell culture: The human alveolar epithelial cell line A549 (ATCC: CCL-185) was grown
in complete cell culture medium consisting of RPMI-1640 medium (Sigma-Aldrich) sup-
plemented with 10% FCS (Lonza), 0.2 mg/ml L-glutamine (Gibco), 50 µg/ml penicillin
(Gibco), 50 µg/ml streptomycin (Gibco), and 100 µg/ml neomycin (Gibco) at 37 ◦C
and in a 5% CO2 atmosphere. Cells were subcultured routinely twice a week at approx-
imately 80-90% confluency using 0.5% Trypsin-EDTA (Sigma-Aldrich).
Cell viability/activity (MTS assay): To assess cell viability/activity the CellTiter96
AQueous One Solution (Promega) containing MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) as the tetrazolium compound
was used according to the manufacturer’s protocol. In brief, 8000 A549 cells were seeded
in 200 µl of complete cell culture medium per well of a 96-well plate (TPP Techno Plas-
tic Products AG) and grown over night under standard cell culture conditions. The
cells were treated the day after with 200 µl per well of different concentrations of the
respective nanoparticles or CdSO4 as the positive control. After appropriate incubation
times (3, 24 and 72 hrs) medium containing stimuli was replaced by 120 µl MTS work-
ing solution (composed of 20 µl MTS plus 100 µl phenol red free RPMI-1640) per well.
The cells were incubated for 60 min at 37 ◦C and 5% CO2 before optical density was
measured at 490 nm in an EL800 microplate reader (BioTEK Instruments).
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Detection of reactive oxygen species (ROS; DCF assay): The formation of ROS was
detected using a DCF (2’,7’-dichlorofluorescein) assay. After entry of the cell-permeant
H2DCF-DA (2’,7’-dichlorodihydrofluorescein-diacetate; Molecular Probes, Invitrogen)
into cells intracellular esterases cleave off the diacetate moiety. The resulting H2DCF
is ROS sensitive and its conversion to the fluorescent form DCF serves as a measure
of ROS production. The assay was carried out in 96-well plates (TPP Techno Plastic
Products AG). 2x104 A549 cells were seeded in 200 µl complete cell culture medium
per well and grown over night under standard cell culture conditions. The day after
the medium was replaced by 100 µl 50 µM H2DCF-DA in Hank’s buffered salt solution
(HBSS) per well and the cells were incubated for 60 min at 37 ◦C and 5% CO2. After two
washing steps with pre-warmed HBSS 100 µl of the respective NP dilutions in HBSS
were applied. 3-Morpholinosydnonimine (Sin-1; Sigma-Aldrich), a nitric oxide donor,
was used at a concentration of 100 µM in HBSS and served as the positive control.
Fluorescence intensities were measured after two hours using an FLx800 fluorescence
microplate reader (BioTEK Instruments) at an excitation wavelength of 485 nm and an
emission wavelength of 528 nm.
Data analysis (MTS and DCF assay): Blank samples containing no cells but being
treated exactly the same way (with NP or chemical control stimuli, all washing steps
(if necessary) etc.) were run with every cell-based assay. Values given in the graphs are
blank corrected and subsequently normalized to the untreated sample. The mean from
at least three independent experiments and the corresponding standard deviations are
shown.
TEM studies: For transmission electron microscopy (TEM) examination, 1x106 A549
cells were seeded in complete cell culture medium into T25 cell culture flasks and were
grown over night at 37 ◦C and 5% CO2. Respective nanoparticles were applied in 10 ml
of complete cell culture medium per T25 flask. After 22 hours of incubation the cells
were detached from the flask using 0.5% Trypsin-EDTA (Sigma-Aldrich) and pelleted
by centrifugation (200 g, 5 min.). The supernatant was discarded and the cells were
resuspended in the remaining drop of medium and sucked up into a capillary tube
(Leica-Microsystems). Therein cells were fixed in 3% glutaraldehyde in a 0.1 M sodium
cacodylate buffer. After a post-fixation step in 2% osmium tetroxide in 0.1 M sodium
cacodylate buffer for 30 min the cells were dehydrated through a graded ethanol series
followed by acetone and finally embedded in Epon resin (Fluka. Ultrathin sections were
contrasted with 2% uranyl acetate and lead citrate29 before observation in a Zeiss EM
900 (Carl Zeiss MicroImaging) operating at 80 kV and a JEOL 2010F retrofitted with
two Cs correctors operating at 80 kV.
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8.2.2 Results
Within this work we were also interested to start to understand the impact of these
nanostructures on humans. To this end we investigated the toxicological aspects of 3D
graphene nanostructures. Toxicologists have already shown that in several cases, espe-
cially after inhalation, nanomaterials induce their toxic effects through an increase in re-
active oxygen species (ROS) [373]. Elevated ROS levels lead to the activation of antioxi-
dant defense pathways in cells. Once a certain ROS threshold is exceeded oxidative stress
mechanisms are induced. This can lead to severe damage of biomolecules (lipids, nucleic
acids, proteins), the induction of inflammatory reactions and finally to cell death (cy-
totoxicity) [373, 374]. According to the ROS-paradigm we assess whether our synthetic
3D graphene nanostructures (both graphene-coated and processed graphene shells) in-
duce ROS overproduction in the human alveolar epithelial cell line A549 using the DCF
(2,7-dichlorofluorescein) assay. Furthermore, by using the MTS (3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxy-methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)) assay, we inves-
tigate if any triggered ROS is sufficient to lead to acute cytotoxic events in these cells.
Both assays were performed using C-shell samples. By analyzing the ROS production
in a cell-free but still biological environment in parallel (see Figure E3 in Appendix E)
we are able to assess any potential nanoparticle intrinsic reactivity that is independent
from the reactions caused by 3D graphene nanoparticle-cell interactions.
DCF assay: Due to technical issues neither the cell-based assay nor the cell-free controls
can be measured quantitatively. Thus, we are not able to set cell-based values off
against values acquired under cell-free conditions. However, qualitative statements on
the reactivity of the samples are possible. In Figure 8.2 it is shown the ROS measurement
performed on A549 cells. The measured fluorescence values are directly proportional to
the amount of ROS in the respective samples. 3-Morpholinosydnonimine (Sin-1) is used
as an assay intrinsic positive control in parallel to all sample treatments.
The two nanoparticle systems analyzed induce a certain amount of ROS with C@MgO
being the least potent inducer, the graphene nanoshells being the most potent inducer.
While the induction is dose-dependent for C@MgO, the graphene nanoshells show a
very high ROS value already at 5 µg/ml increasing only marginally with 10 µg/ml.
With higher graphene nanoshell concentrations fluorescence values further decline. In
nanoparticle-related control experiments (see Figure E4 in Appendix E), the C@MgO
particles show only marginal intrinsic reactivity indicating that ROS values seen in
Figure 8.2 are mainly due to cellular reactions. However, the graphene-shells lead to a
considerable, dose-dependent increase in fluorescence values by themselves, i.e. without
cellular contribution. This indicates that the cellular reactions seen in Figure 8.2 are
not solely due to cellular reactions but may also result from direct reactions of the
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Figure 8.2: All three nanomaterials tested lead to elevated ROS levels. ROS formation
was measured in A549 cells after two hours of treatment with indicated concentrations
of C@MgO and graphene-shells using the DCF assay. “0 µg/ml” constitute the solvent
controls, which correspond to 51 ppm Pluronic F-127 R©. Sin-1 (100 µM) was used as
the positive control. Original fluorescence values are blank-corrected and normalized
to untreated samples. The data represent the mean of three independent experiments
and the standard deviation.
sample nanostructures with the dye. Furthermore, we see that increasing amounts of
graphene-shells, and to a much lesser extent also for C@MgO nanoparticles, quench an
existing DCF signal thus explaining the reduction in fluorescence seen in Figure 8.2 for
the C-shells (see Figure E4 in Appendix E).
MTS assay : The question as to whether the amount of ROS resulting from the treat
3D graphene nanostructures is sufficient to cause cytotoxicity was investigated with
the MTS assay. In this study, A549 cells were incubated for 3, 24 and 72 hours with
increasing concentrations of C@MgO and graphene nanoshells, respectively. As can be
seen in Figure 8.3 no signs of cytotoxicity, i.e. no reduction in enzymatic activity, was
observed for any of the 3D graphene nanoctructures for all the time points investigated
up to three days.
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Figure 8.3: Cell viability is not influenced by any of the nanomaterials tested. A549
cells were treated for 3, 24 and 72 hours with the indicated nanomaterial concentrations
before the MTS cell viability assay was performed. CdSO4 served as the positive control
known to induce cell death in this system. “0 µg/ml” constitute the solvent controls,
which correspond to 51 ppm Pluronic F-127 R©. Original OD(490) values are blank-
corrected and normalized to untreated samples. Data represent the mean of three
independent experiments and the standard deviation.
Nevertheless, the assay internal positive control CdSO4 shows that toxicity can be re-
liably detected at each time point. Potential interference reactions were again assessed
in cell-free control experiments. The measurements indicate no significant interference
problems for the C@MgO nanoparticles. In contrast increasing concentrations of C-
shells lead to a marked increase in OD values at 490 nm (without cellular contribution).
As no catalytic activity of the particles could be detected, the control wells run with
every cell-based experiment (blanks) can be used to correct for this interference. Thus,
the blank corrected values given in Figure 8.3 are comparable between the three nano-
materials as well as the control chemical (CdSO4). It should be noted however, that
despite these initial investigations indicating limited toxicity, whether or not the ROS
levels seen here are already above a critical threshold that might lead to long term or
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chronic effects is unclear. Damage to lipids, proteins and nucleic acids as well as inflam-
matory reactions must also be considered. All of these events could occur without being
noticed immediately and might result, for example, locally in some part of the body,
in adverse health effects. Indeed, greater studies are required to fully comprehend any
potential health risks of these and other nanoparticles in general.
8.2.3 Uptake studies
The uptake of the 3D graphene nanostructures into A549 cells and their potential impact
on cell morphology was analyzed by TEM. To this end, A549 cells were incubated with
40 µg/ml of graphene nanoshells for 22 hours. Representative micrographs are shown
in Figure 8.4B. The red square region shows an internalization region containing the
graphene nanoshells. In Figure 8.4C shows the red region zoomed and the nanoshells
are depicted in with arrows. The agglomerates appear intracellularly most likely in mem-
brane enclosed compartments (Figure 8.4C). For morphological comparison untreated
cells are shown in Figure 8.4A. Even though considerable amounts of 3D graphene nanos-
tructures are internalized the cells appear remarkably healthy. To further address the
issue of cell morphology we had a look at the actin cytoskeleton of A549 cells. Figure
E5 in Appendix E shows a comparison of untreated cells and cells that were incubated
with 40 µg/ml of C@MgO and graphene nanoshells. Neither conventional DIC imaging
nor fluorescence microscopy yield any influence of the graphene nanostructures tested
on cell morphology. These results underscore the cell viability data (MTS) indicating
no major impact of the elevated ROS levels on overall cell performance. High resolution
TEM images were also acquired and the graphitic nature of the graphene nanoshells can
also be observed (Figure 8.4D).
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Figure 8.4: TEM analyses reveal that graphene nanoshell particles enter A549 cells
without influencing cell morphology. Panel A is a representative TEM micrograph of
an untreated A549 cell. Panel B shows A549 cells treated with 40 µg/ml graphene
nanoshell particles for 22 hours. The red square shows the region surrounded by a
membrane and the nanoparticles are inside. In Panel C a zoomed image of the inter-
nalization region. Some of the graphene nanoshell particles are shown. In Panel D and
increase in magnification can show the graphene layers of nanoshells.
8.3 Summary
In this chapter it was shown that the biological tests performed with the 3 dimensional
graphene shells in EMPA induce high levels of ROS, however the in vitro test do not
detect any subsequently acute toxicity of the graphene nanoshells in the tested cell line.
The uptake studies showed that the graphene nanoshells are internalized in agglomerates
by the tested cell line and no morphological differences were observed between the treated
and untreated cells.

Chapter 9
Summary
Graphene-based nanostructures have been synthesized and systematically characterized
for biomedical applications. The results suggest that even small changes in the mor-
phological aspects of nanoparticles can be recognized by cells. Thus, it is necessary
to produce and study nanoparticles with defined morphology and to understand their
exact role in biological systems. Graphene-based nanoparticles present a high potential
for biomedical applications. However their use the daily medical routine can only be
realistically achieved after our knowledge on how every aspect of graphene nanoparticles
interact with biological cells as well as any biological response they may trigger.
The first part of this work focused on the synthesis of different graphene-based nanopar-
ticles as well as the synthesis route used. The results presented in chapter 4 demontrate
that it was possible to synthesize monodisperse iron oxide nanoparticles coated with
graphene using a colloidal chemistry route where iron oleate is the precursor of the
nanoparticles. Next, it was shown that using the Hummers method is was possible to
oxidize graphite and using sonication it was possible to controllably reduce the size of
the graphene oxide flakes. Finally, it is shown that it is possible to use commercially
available magnesium oxide nanoparticles as a template to synthesize empty graphene
nanoshells. All techniques can render large amounts of material, which makes them
potentially suitable for future mass production and commercialization.
In chapter 5 the characterization of the monodispersed iron oxide nanoparticles coated
with graphene was demonstrated. The four studied samples contain nanoparticles with
a coating, which presents graphitic nature as shown in the Raman spectra. IR spec-
troscopy analysis of the samples showed the presence of different functional groups. The
hysteresis curves of all samples showed very low values of coercivity, suggesting that they
present a superparamagnetic behavior at room temperature. The different saturation
magnetization observed in the hysteresis among all samples supports the XRD studies,
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which suggests a mix of different phases of iron oxide. The derivative of the magnetiza-
tion curves measured according temperature showed that the blocking temperature of all
samples are below the room temperature, supporting the low coercivity interpretation
of the hysteresis curves. The same plot of MxT suggest the presence of very small par-
ticles (peak for blocking temperature around 10 K). As expected the broader diameter
sample contains different blocking temperatures suggesting the presence of nanoparticles
with different diamters. The four as-produced samples containing nanoparticles ranging
from approximately 10 to 20 nm tested for their cytotoxity and uptake on both non
cancerous and cancerous cells. The cell viability is mainly determined by the concen-
tration of nanoparticles used. The results showed no correlation between the size and
the cytotoxity data. The cancerous cell line showed the least decrease in viability for
all the sizes of nanoparticles tested. Despite the cytotoxicity tests suggest that the size
of nanoparticles are not reducing the cell viability, the uptake studies suggests that the
cells can indeed discriminate between the size of nanoparticles. The small nanoparticles
(9.7 nm) are least internalized than the bigger nanoparticles (20.3 nm). This can ulti-
mately define the efficiency of these small nanoparticles for hyperthermia or drug delivery
approaches, since their uptake is crucial in the accumulation of the nanoparticles in the
target tissue. It is known that magnetic nanoparticles can form agglomerations and this
can influence how cells interact with the nanoparticles. The data also provides evidence
that the nanoparticles can be internalized both individualy and in clusters. Moreover,
the data show that the reduction in the formation of cluster can increase the viability of
cells up to 40 %. This suggests that the more dispersed the nanoparticles are the more
biocompatible they become. Despite iron oxide nanoparticles are the only nanoparticle
system approved to be clinically used, the results presented in the literature are still very
controversial. The results shown in this work shows that cells recognize even slightly
changes in size of nanoparticles. This strongly suggests that it is still necessary to study
systematically the influence of morphology of iron oxide nanoparticles in biological cells.
The nature of the iron oxide coating was further studied and in chapter 6 it was shown
that despite the coating of iron oxide nanoparticles presents a graphitic nature, it is
still possible to find traces of oleic acid. This organic molecule cannot be avoided in
this synthesis route even after thorough rinsing. Using an electron beam of a TEM we
demonstrated that it is possible to graphitize this molecule and coat iron oxide nanopar-
ticles with few layers of graphene. The control over the thickness of the graphene coating
on nanoparticle is very desirable, but difficult to achieve with exisiting techniques. Our
in situ data suggests that it is possible to control the thickness of the graphene coating
by controlling the thickness of the oleic acid on the nanoparticles. It was possible to
produce coatings varying from 2 up to 12 graphene layers with an electron beam only by
changing the oleic acid thickness. It was also demonstrated that the growth of graphene
could be reproduced in a larger scale by annealing the nanoparticles inside a CVD oven.
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The annealing rendered nanoparticles with graphene coating and also reduced the iron
oxide nanoparticle to pure iron. This dramatically improves the magnetic properties of
the nanoparticles for applications, e.g. hyperthermia. The heating experiments were
performed and demonstrated to increase the applicability of these nanoparticles for hy-
perthermia treatment. A better understanding of the sintering process needs to be
further studied since the annealing of iron oxide nanoparticles for longer periods can
influence their size. The same study showed that using the same annealing process of
pure oleic acid on silicon oxide substrates, it was possible to grow graphene flakes. This
suggests that organic molecules like oleic acid can be used as a precursor to both coat
nanoparticles and larger surfaces with graphene layers.
This work follows with the study of nanographene oxide flakes. Two distinct samples
of nanographene oxide, each containing different average flake sizes were characterized
and their cytotoxicity and uptake on both cancer and non cancerous cells was evalu-
ated in chapter 7. The characterization of the material showed that both nanoparticles
have different oxygen species groups. The presence of these functional groups renders
these nanoparticles optimum dispersion in physiological environment. The cytotoxicity
of nanographene oxide samples was evaluated and, like for the iron oxide nanoparticles
coated with graphene, the concentration plays a role in the cell viability. The more con-
centrated the solution the more cytotoxic it becomes. In this case it is possible to notice
that the smaller particles showed less cytotoxicity effects than bigger flakes. However,
this difference in cytotoxicity depending on the nanoparticle size can only be observed
for one incubation period (12 hours). After this period, the viability appears to be sta-
bilize and becomes similar between the two nanographene samples. The uptake of the
nanographene oxide was also studied with a TEM, but no differences in the internaliza-
tion of different sizes could be observed. The TEM micrographs could only show that
both nanoparticle sizes can be internalized by both cancer and non cancerous cells, but
the data do not provide evidence of a preference for one specific size studied.
Finally, in chapter 8 the graphene nanoshells were characterized and also the cytotoxicity
and uptake evaluated. In this chapter it was shown that the biological tests induce high
levels of reactive species in the studied cell. The in vitro tests do not detect any acute
cytotoxicity of the graphene nanoshells. The uptake studies showed that the graphene
nanoshells are internalized in agglomerates by the tested cell line and no morphological
differences were observed between the treated and untreated cells. As a final conclu-
sion, this work shows that graphene-based nanoparticles should be synthesized to render
samples with a homogeneous size dispersion and high purity. This material should be
systematically characterized prior to the biological evaluation. Only then is it possible
to accurately start to understand and correlate the physical parameters with respect to
any biological response triggered. In the case of this work it was demonstrated that even
slight changes in the size of iron oxide nanoparticles triggered different uptake in cells.
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Nanographene oxide with different sizes also exhibited different cytotoxicity responses
depending on the flake size. The graphene nanoshells were shown to be a potent reactive
oxygen species inducer, however this did not influence the cytotoxicity and uptake of
the nanoparticles.
Hence, individual morphological aspects of sp2 carbon nano species are demonstrated
to be relevant in biological environments, even for size variations within 10 nm. Such
studies are crucial for the efficient design of nano-carbon platforms for biomedical ap-
plications.
Appendix A
Synthesis of nanoparticles
Figure A.1: The four sample of iron oxide nanoparticles coated with graphene. From
panels A-D it is possible to see the nanoparticles with 20.3, 16.8, 14.8 and 9.7 nm,
respectively.
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Figure A.2: The two nanographene oxide in aqueous solutions. The sample cannot be
dried because the layers agglomerates and form graphene oxide buckypaper and cannot
be easily dispersed. Panels A and B correspond to the samples containing nangraphene
oxide nanoparticles with 277 and 89 nm, repectively.
Figure A.3: The MgO nanoparticles powder is shown in panel A. After the CVD
route was exposed to ethanol vapor at 775 ◦C.
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Appendix B
Evaluation of iron oxide
nanoparticles coated with
graphene
Figure B.1: Percentage viability of different cell lines in dependence on the nanoparti-
cle diameter for three different nanoparticle concentrations using the MTT assay (green:
1 µg/mL, orange: 10 µg/mL, white: 100 µg/mL) for A) HeLa Kyoto, B) human os-
teosarcoma U2OS (GFP-53BP1), C) NIH 3T3 fibroblasts and D) Macrophages J7442.
Error bars represent the standard deviation. The histograms presented in panels A-D
show the MTT tests conducted for the 12 hours incubation period of the NPs with
the various cell lines. As can be seen by the viability values, the obtained results
show no evident toxic response cause by the NPs for any of the concentrations tested.
Furthermore no size dependence in the range tested could be observed.
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Figure B.2: Panel A and B show the histograms of the MTT tests conducted for the
12 hours incubation. In panel A the tests is shown for the non sonicated nanoparticles,
whereas in panel B the same test was performed for the sonicated nanoparticles. No
significant difference between both tests can be observed. In panels C and D the trypan
blue test for the 12 hours incubation can be seen. The comparison of the percentage
cell viability for the different cell lines for two nanoparticle diameters (green: untreated
cells, orange: 10 nm Nanoparticle and white: 20 nm Nanoparticle 12 h incubation)
is provided. The nanoparticle concentration in each case is 10 µg/mL. Here again no
significant change in viability can be observed between the sonicated and non sonicated
samples.
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Figure B.3: Panels A-K show light microscopy images taken from live observation of
macrophage cells during the 48 h incubation with nanoparticles at a concentration of
1 µg/ml. In panel A-C the cells get in contact with some visible clusters. The clusters
appear to attach to the cell and move together with the cells. In panel D it is possible
to observe a cell death, which remains unchanged until some neighboring cells approach
and clear the region (panel H and J). In panel G it is possible to see that the cluster in
contact with the cells “broke” into a smaller piece, which moves with the cell movement.
It was also possible to observe that the macrophages appear to agglomerate around the
clusters. As these cells are part of the immune system, this behavior could be assigned
as a cellular response to unknown particles in the surroundings where they are. The
uptake could not be confirmed using the z-stacking as shown in panel L.
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Figure B.4: Panels A and B show TEM images of HeLa cells incubated for a period
of 12 hours with the 9.7 and 20.3 nm NPs respectively, whereas panels C and D show
the macrophages also incubated for 12 hours with the 9.7 and 20.3 nm respectively.
Our observations showed that the smaller NPs are hardly internalized by both cell lines
(panels A and C). The uptake of the larger NPs could be easily observed for both
cell lines. This suggests that although in the toxicity tests no apparent difference in
viability for both samples was observed, the cells interacted differently with the NPs.
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Figure B.5: Panels A and B show TEM images of HeLa cells incubated for a period of
24 hours with the 9.7 and 20.3 nm NPs respectively, whereas panels C and D show the
macrophages also incubated for 24 hours with the 9.7 and 20.3 nm respectively. The
new experiments show that the same pattern of uptake can be observed. Despite more
frequently observed, the uptake of the smaller NPs is again difficult to observe. The
uptake of the larger NPs the uptake appears to remain constant and similar to the lower
incubation period. This reinforces our initial assumption that cells can discriminate
between the two samples even in a small range of sizes.
Appendix C
Graphitization of oleic acid
Figure C.1: In Panels A, B, C and D it is possible to see the diameter distribution
measured using the TEM for the annealing time 0, 15, 60 and 720 min respectively.
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Figure C.2: Average thickness of the nanoparticle coating.
Figure C.3: In panel A the XRD pattern of all the samples as shown in the manuscript
are provided and in panel B it is possible to see a magnified region where the most
significant changes upon annealing occur. The arrows highlight peaks that change after
the annealing process. Changes begin even after 15 minutes annealing, the changes
continue and after 720 the reflexes corresponding to the (220) and (311) orientations
completely disappear.
Appendix C. Graphitization of oleic acid 125
Figure C.4: In Panels A, B, C and D it is possible to see the temperature increase of
the particles dispersed in water for the annealing time 0, 15, 60 and 720 min respectively.
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Figure C.5: Panels A, E, I and H show an example of a particle annealed at 500
◦C for 0, 15, 60 and 720 minutes, respectively. Each of the panels immediately under
each particle shows a magnefied area (red square) of their crystalline lattice and the
corresponding Fourier transform of this region. By measuring the distance between the
reflexes in the intensity profile (panels D, H, L and P) it was possible to determine
the phase of the material. The data shows γ − Fe2O3 was present for the as-produced
particle, as well as for the 15 and 60 minutes annealing was found and their corre-
sponding peaks are the (320), (320) and (200) orientations, respectively. For the 720
minutes thermal annealing iron particles were found and its corresponding peak was
(110) orientation. This data analysis is in agreement with the XRD results.
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Figure C.6: Panel A shows the diameter distribution and panel B the height distribu-
tion of the graphene nanoflakes. Both parameters were measured using AFM as shown
in panel C, where a profile of the nanoflake was taken and the height and diameter were
extracted as shown in panel D. This procedure was followed for around 100 different
nanoflakes and that the profile was measured twice for each nanoparticle.
Figure C.7: Raman of the graphene nanoflake showing the D and G modes as well
as the 2D mode, which is appearing with the D+G peak.

Appendix D
Evaluation of nanographene oxide
Figure D.1: Panels (A) shows the statistics of the NGO with 277 nm diameter. The
diameter was measured based on SEM images, while in panel (B) shows the statistics
of height for 277 nm NGO sample. The height was based on AFM images and indicates
that the NGO has in average 4 layers. Panels (C) shows the statistics of the NGO with
89 nm diameter. The diameter was measured based on SEM images, while in panel (D)
shows the statistics of height for 89 nm NGO sample. The height was based on AFM
images and indicates that the NGO has in average 6 layers.
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Figure D.2: Graphic shows the EDX spectra of both NGO samples collected in the
TEM microscope and suggest no contamination. The Copper (Cu) peak is coming from
the TEM grid.
Appendix E
Evaluation of graphene nanoshells
 
Figure E.1: Graphitic shells after MgO core removal with HCl. The shape of the
shells varies with some being round or cubic.
Figure E.2: (A) Energy dispersive spectroscopy (EDS) spectrum of graphene coated
magnesia nanoparticles (B) EDS spectrum of carbon shells after hydrochloric acid re-
moval of MgO
Detection of reactive oxygen species (ROS; DCF assay): Cell-free control set-
tings: Potential nanoparticle interference with the DCF assay was assessed in a cell
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free setup. Two possibilities were examined: (1) Intrinsic particle reactivity: Do NP
process the H2DCF molecule by themselves without the involvement of cellular reac-
tions? (2) Quenching effects of the particles: Do NP quench an existing fluorescence
signal? (1) To assess the intrinsic reactivity of NP the H2DCF-DA molecule (non-
fluorescent, not sensitive to ROS) has to be deacetylated chemically to obtain the ROS
sensitive H2DCF. Therefore, 7.5 volumes of 1 mM H2DCF-DA in methanol were added
to 30 volumes of 0.01 M NaOH and stirred in the dark for 30 min at room temper-
ature (RT). To stop the reaction 112.5 volumes of 33 mM NaH2PO4 were added and
stirred shortly. The resulting 50 µM H2DCF solution was stored for a maximum of one
week at 4 ◦C in the dark before being used. 50 µl of this 50 µM H2DCF solution were
distributed per well of a 96-well plate and 50 µl of the respective NP as well as Sin-1
dilutions in Hank’s buffered salt solution (HBSS) were added. Fluorescence intensities
were measured after two hours using an FLx800 fluorescence microplate reader (BioTEK
Instruments) (2) The fluorescent DCF molecule is commercially available (Sigma) and
is used at a concentration of 2.5 µM. 50 µl were distributed per well of a 96-well plate
and 50 µl of the respective NP dilutions were added. Fluorescence intensities were
measured after two hours using an FLx800 fluorescence microplate reader. Results:
According to the ROS measurements in A549 cells shown Figure 8.2 (main text) ROS
induction in a cell-free environment is depicted in Figure E3A. While C@MgO particles
lead to only a marginal increase in fluorescence values the intrinsic reactivity of C-shells
towards H2DCF is more prominent and dose-dependent. Results from quenching exper-
iments are shown in supplementary figure E3B. Likewise to the reactivity measurements
in A C@MgO interference is marginal. A 20% reduction is seen starting around 125
µg/ml and 62.5 µg/ml, respectively. However C-shells reduce the DCF signal already at
7.8 µg/ml by approximately 20%.
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Figure E.3: Cell-free analyses of C@MgO and C-shell interference with the DCF
assay. (A) Intrinsic reactivity of the NP: The ROS-sensitive molecule H2DCF (25 µM)
was incubated for two hours with the indicated concentrations the respective NP. Sin-1
(50 µM) served as a positive control. The untreated sample received 25 µM H2DCF
only. (B) Quenching effects: 2.5 µM of the fluorescent molecule DCF were incubated
with the indicated concentrations of the three different NP for one hour. In both
setups (A&B) “0 µg/ml” constitute the solvent controls. Original fluorescence values
are blank-corrected and normalized to untreated samples. Data represent the mean of
three independent experiments and the standard deviation.
Analysis of cell viability/activity (MTS assay): Cell-free control settings: Three
possibilities of potential nanoparticle interference with the MTS assay were examined
in cell-free settings: (1) Intrinsic OD of the particles. (2) Intrinsic particle reactivity:
Do NP process MTS without involvement of cells? (3) Particle impact on processed
MTS (formazan salt): Do NP somehow disturb/influence an existing signal? The OD
of bare NP (1) was assessed in RPMI-1640 without phenol red. To investigate the
particle’s reactivity towards MTS (2) the MTS reagent (as delivered) was diluted in
RPMI-1640 without phenol red according to the manufacturer. And to retrieve the
formazan salt (3) the MTS reagent (as delivered) was diluted in RPMI-1640 without
phenol red as described above and reduced by adding Na2SO3 to a final concentration
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of 1 mM. The resulting brownish solution contains the reduced formazan salt. In all
three cases 100 µl of the respective medium (medium alone, medium with MTS, medium
with formazan) were distributed per well of a 96-well plate and 100 µl of the respective
NP dilutions in 160 ppm Pluronic F-127 R© were added. After 60 min of incubation at
37 ◦C and 5% CO2 (corresponding to cellular incubation times and conditions) OD was
measured at 490 nm in an EL800 microplate reader (BioTEK Instruments). Results:
“Unprocessed” OD values measured at 490 nm are shown in Figure E4A and B for
C@MgO and C-shells, respectively. Each graph shows three curves resulting from mea-
surements in RPMI-1640 without phenol red (green triangles), in MTS (red squares)
and in formazan (blue diamonds). All three NP elevate OD values in a dose-dependent
manner. The slopes of all three curves are the same. This indicates that bare NP in fact
show a certain OD but are NOT reactive, i.e. do not process MTS or formazan. Blank
values, measured in RPMI-1640 only (green triangles), can thus be subtracted from val-
ues measured in MTS and formazan. The resulting blank-corrected values are presented
in Figure E4A’ and B’ for C@MgO and C-shells, respectively. The increase in OD at
higher NP concentrations (especially seen for the C-shells) can be totally corrected for.
In conclusion, these interference tests justify the approach described in the main text to
simply subtract the blank values measured side by side with every cell-based assay.
Figure E.4: Cell-free analyses of C@MgO and C-shell interference with the MTS
assay. Please find details in the main text.
Analysis of actin cytoskeleton by immunofluorescence microscopy: To assess the
morphology of the actin cytoskeleton, 1x105 A549 cells were seeded in complete cell cul-
ture medium on top of sterile 12 mm glass cover slips in 24-well plates. Cells were grown
over night at 37 ◦C and 5% CO2. 40 µg/ml of the respective nanoparticles were applied
in 500 µl of complete cell culture medium per well. After 22 hours of incubation cells
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were washed twice carefully with pre-warmed (37 ◦C) phosphate buffered saline (PBS)
and fixed in 4% Paraformaldehyde (PFA) in PBS for 10 min at room temperature (RT).
After three washing steps in PBS cells were permeabilised for 30 min at RT using dilu-
tion buffer (0.5% bovine serum albumin (BSA), 0.5% Tween-20 R© in PBS). Actin fibers
were visualized using Phalloidin-Alexa546 or Phalloidin-Alexa488 (Molecular Probes) at
a final concentration of 2 U/ml (corresponding to 66 nM). Nuclei were counterstained
with 4’,6’-Diamidin-2-phenylindol (DAPI; Sigma) at a final concentration of 0.1 µg/ml.
Both dyes were applied simultaneously in dilution buffer for 3 hours at RT. After 3
final washing steps in PBS cover slips were mounted onto microscopic slides in Mowiol
(Fluka), dried over night at 37 ◦C and examined either under a epifluorescence micro-
scope (Axio, Imager.M1, Zeiss) or a confocal laser scanning microscope (LSM 780, Zeiss)
as indicated in Figure E5. Results: Figure E5 shows a comparison of untreated A549
cells with cells incubated for 22 h with 40 µg/ml C@MgO and C-shells, respectively. As
cells were in all cases not evenly distributed over the coverslips (resulting in areas with
more or less cells) we show two representative images (panels A and B). C-shells appear
as large agglomerates in discrete spots while C@MgO particles cannot be seen at all in
this magnification (Figure E5A and B). The overall cell number seems to be similar in all
samples. (This is also reflected in the MTS assay results.) Furthermore, epifluorescence
(Figure E5C and C’) as well as CLSM (Figure E9D) pictures clearly show that there
are no differences in cell spreading, actin cytoskeleton organization and morphology in
general. We thus conclude that all three nanoparticles tested do not influence A549 cell
performance.
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Figure E.5: Assessment of the actin cytoskeleton by fluorescence microscopy of un-
treated, C@MgO and C-shell treated A549 cells. A and B: DIC images of two represen-
tative areas of view. C: epifluorescence images. Actin cytoskeleton in green (Phalloidin-
Alexa488), nuclei in blue (DAPI). C’: higher magnification of selected areas depicted
in C. D: CLSM maximum intensity projections of the actin cytoskeleton shown in red
(Phalloidin-Alexa546) and nuclei in blue (DAPI). Please find details in the text.
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